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In the name of God, most Gracious, most Compassionate 
O mankind, if you should be in doubt about the Resurrection, then [consider that] indeed, We 
created you from dust, then from a sperm-drop, then from a clinging clot, and then from a 
lump of flesh, formed and unformed – that We may show you. And We settle in the wombs 
whom We will for a specified term, then We bring you out as a child, and then [We develop 
you] that you may reach your [time of] maturity. And among you is he who is taken in [early] 
death, and among you is he who is returned to the most decrepit [old] age so that he knows, 
after [once having] knowledge, nothing. And you see the earth barren, but when We send 
down upon it rain, it quivers and swells and grows [something] of every beautiful kind. 
 
(AlQuran; 22:5)  
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SUMMARY 
Telomeres are specialized nucleoprotein structures that protect chromosomal ends, and their 
lengths are species-specific. Telomeres serve as a mitotic clock as they get shortened with 
each round of replicative cycle until the cell reaches a state of replicative senescence. Thus, 
telomeres are crucial for genome integrity and cell viability and are thought to influence 
organismal lifespan. However, a direct correlation between telomere length and life 
expectancy across several species is not established. Telomere length and respective 
chromosomal integrity can be preserved by the activity of the enzyme telomerase, which is 
also involved in many other cellular functions related to tissue homeostasis and ageing. 
Different biochemical and genetic factors have been proven to impact telomere lengths and 
integrity. Likewise, it has been shown that ultra-long telomeres in inbred mouse strains arise 
as a result of consanguineous breeding strategies and lack of genetic refreshment. Most of the 
knowledge about the structural and functional biology of telomeres was obtained from 
observations made in somatic cell types. However, the role of telomeres in the brain is still 
not well understood because of the low replicative capacity of this organ, which is further 
restricted to certain cell populations excluding neurons. However, recent observations also 
suggest atypical cell cycle activity in nominally postmitotic neurons under certain stress 
conditions. Therefore, in this study we assessed the telomere length dynamics and telomerase 
activity in the ageing and diseased murine brain.  
In the first part of the study, we determined the impact of ageing and different breeding 
strategies on the relative telomere length (RTL) in the brain of two C57BL/6 strains as a 
function of cell cycle activity. We show that telomere shortening eventuates in the ageing 
murine brain in both, a replication-dependent and also -independent manner. This observation 
was restricted to conditions of hermetic inbreeding and found to be more pronounced in the 
dividing cell moiety of the brain. Moreover, the C57BL/6 mouse colony, which was held in 
the absence of genetic refreshment, exhibited a substantially faster rate of age-associated 
telomere erosion in neural cell populations of the brain. Additionally, in contrast to the 
conventionally inbred strain, telomerase reverse transcriptase (TERT) activity remained 
unchanged with ageing in the genetically non-refreshed strain. Sustained levels of TERT 
activity in the hermetically inbred mice with ageing coincided with upregulated levels of 
RelA, a central nervous system (CNS)-prevailing subunit of the classical NF-κB cascade for 
which a feed-forward interaction with TERT has recently been demonstrated in a malignant 
environment. In contrast, reduced TERT activity level in the refreshed murine strain was 
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associated with a significant age-associated reduction in the expression of c-Rel, another 
subunit of the classical NF-κB cascade. 
In the second part of the study, we analyzed the telomere length and telomerase activity in a 
murine model mimicking amyotrophic lateral sclerosis (ALS) pathology. ALS is a relentless 
neurodegenerative disorder, which is currently understood to originate from a complex, multi-
facetted pathobiology implicating a precocious ageing process. Using the hSOD1
G93A
 
transgenic mouse model, our data revealed unexpected telomere lengthening in the cortex and 
spinal cord, which paralleled disease progression and the development of severe neurological 
deficits. Furthermore, the different pattern of telomerase activity observed for several brain 
regions and the spinal cord with disease progression points to region-specific regulation of 
telomerase activity in the mature and diseased CNS.  
In conclusion, our study provides evidence for a differential regulation of telomere length and 
telomerase activity in the ageing and diseased CNS. Further studies are needed to investigate 
the role of specific neural cell types in the telomere erosion process, in particular of post-
mitotic neurons and specifically of motor neurons in an ALS-like environment, and to define 
a putative mechanistic link between TERT and NF-κB in the senescent brain. Likewise, it will 
be interesting to reveal the mechanisms responsible for the observed telomere lengthening 
alongside with the progression of ALS-related neurodegeneration. 
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ZUSAMMENFASSUNG  
Telomere sind spezialisierte Nukleoprotein-Komplexe, die chromosomale Endstrukturen 
schützen und deren Längen Spezies-spezifisch sind. Telomere dienen als ‚mitotische Uhr‘, da 
sie  sich mit jedem Zellzyklus verkürzen, bis die Zelle einen Zustand der replikativen 
Seneszenz erreicht. Telomere sind daher entscheidend für die Genomintegrität und die 
Lebensfähigkeit der Zelle. Außerdem  wird angenommen, dass sie die Lebenszeit von 
Organismen beeinflussen, obwohl eine direkte Korrelation zwischen Telomerlänge und 
Lebenserwartung, über mehrere Spezies hinweg, nicht etabliert ist. Die Telomerlänge und 
assoziierte chromosomale Integrität können durch die Aktivität des Enzyms Telomerase 
erhalten werden. Die Aktivität der Telomerase ist auch an vielen anderen zellulären 
Funktionen beteiligt, die mit Gewebehomöostase und Alterung zusammenhängen. 
Verschiedene genetische und biochemische Faktoren beeinflussen die Telomerlänge und -
integrität. In ähnlicher Weise wurde gezeigt, dass ultralange Telomere in Inzucht-
Mausstämmen ein Resultat konsanguiner Zuchtstrategien und fehlender genetischer 
Auffrischung darstellen. Wichtige Erkenntnisse über die strukturelle und funktionelle 
Biologie der Telomere wurden über Beobachtungen an verschiedenen somatischen Zelltypen 
gewonnen. Die Rolle der Telomere im Gehirn ist jedoch aufgrund der geringen 
Replikationskapazität dieses Organs, die außerdem auf bestimmte Zellpopulationen 
beschränkt ist und Neurone ausschließt, noch nicht gut verstanden. Jedoch gibt es neuerdings 
Hinweise, dass unter bestimmten zellulären Stresskonditionen eine unkonventionelle 
Zellzyklusaktivierung auch in nominell postmitotischen Neuronen stattfinden kann. Daher 
untersuchten wir in dieser Studie die Telomerlängendynamik und die Telomeraseaktivität im 
alternden und erkrankten murinen Gehirn. 
Im ersten Teil der Studie untersuchten wir den Einfluss von zellulärer Alterung auf die 
relative Telomerlängendynamik im Gehirn in Abhängigkeit von Zellzyklusaktivität, u.z. 
vergleichend in zwei C57BL/6-Stämmen mit unterschiedlicher Zuchtstrategie. Wir konnten 
zeigen, dass eine Telomerverkürzung unter hermetischen Inzuchtbedingungen im alternden 
murinen Gehirn sowohl in replikationsabhängiger als auch -unabhängiger Weise stattfindet. 
Dieser Effekt war beschränkt auf Tiere mit hermetischer Inzuchtgenetik und stärker in 
replikativen als in non-replikativen Zellpopulationen ausgeprägt. Darüber hinaus zeigte die 
C57BL/6-Kolonie, die ohne genetische Auffrischung gehalten wurde, eine Akzelleration an 
Alters-assoziierter Telomer-Erosion in neuralen Zellpopulationen des Gehirns. Außerdem 
blieb das relative TERT-Aktivitätsniveau im genetisch nicht-aufgefrischten Stamm, im 
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Gegensatz zum konventionellen Inzuchtstamm, im Alter unverändert. Das stabilisierte TERT-
Aktivitätsniveau, das  für den gealterten hermetischen Inzucht-Stamm detektiert wurde,  ging 
mit einer hochregulierten Expression von RelA einher. RelA ist eine im zentralen 
Nervensystem (ZNS) vorherrschende Untereinheit der klassischen NF-κB-Kaskade, für die 
kürzlich in  einem Tumormodell eine positive Interaktion mit TERT nachgewiesen wurde. Im 
Gegensatz hierzu war das reduzierte TERT-Aktivitätsniveau im genetisch aufgefrischten 
Stamm mit einer signifikanten Alters-assoziierten Reduktion der Expression von c-Rel, einer 
anderen Untereinheit der klassischen NF-κB-Kaskade, assoziiert. 
Im zweiten Teil der Studie wurde die Telomerlänge und Telomeraseaktivität in einem 
murinen Modell, welches der Amyotrophen Lateralsklerose (ALS) ähnliche 
Krankheitskonditionen nachbildet, analysiert. Bei der ALS handelt es sich um  eine infauste 
neurodegenerative Erkrankung, der eine komplexe multifaktorielle Pathobiologie  zugrunde 
liegt, die wiederum einen vorzeitigen Alterungsprozess impliziert. Unter Nutzung des 
hSOD1G93A transgenen Mausmodells zeigen unsere Daten eine unerwartete 
Telomerverlängerung sowohl im Cortex als auch im Rückenmark, die mit dem 
Krankheitsverlauf und der Entwicklung schwerer neurologischer Defizite korreliert. Darüber 
hinaus weist das unterschiedliche Muster der Telomeraseaktivität in den verschiedenen 
Hirnregionen und im Rückenmark, welches im Laufe der Krankheitsprogression beobachtet 
wurde, auf eine regionsspezifische Regulierung der Enzymaktivität im adulten und erkrankten 
ZNS hin. 
Zusammenfassend liefert die Studie Hinweise für eine differentielle Regulation der 
Telomerlänge und Telomeraseaktivität im alternden und erkrankten ZNS. Weitere Studien 
sind erforderlich, um die Rolle spezifischer neuraler Zelltypen im Telomer-Erosionsprozess, 
insbesondere von postmitotischen Neuronen und speziell von Motorneuronen, unter ALS-
ähnlichen Bedingungen zu untersuchen und eine mutmaßliche mechanistische Verbindung 
zwischen TERT und NF-κB im seneszenten Gehirn zu konsolidieren. Ebenso wird es 
interessant sein, jene Mechanismen zu identifizieren, die in Assoziation mit dem Fortschreiten 
der ALS-ähnlichen Neurodegeneration für die beobachtete Telomerverlängerung  
verantwortlich sind. 
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1 INTRODUCTION 
 Telomeres 1.1
Telomeres are highly conserved, non-coding DNA elements at the terminal ends of eukaryotic 
chromosomes (Moyzis et al., 1988). Mammalian telomeres are basically nucleoprotein 
structures comprising hexameric 5’-TTAGGG-3’ repeats, which are shielded by a hexa-
protein complex, the Shelterin complex (Fig. 1). The extension of telomere motif repetitions 
ends in a long G-rich single strand overhang (Wright et al., 1997). Telomeric repeat binding 
factor 2 (TRF2) is crucial for binding to the duplex DNA and promotes the invasion of the 3’ 
overhang into the duplex telomere repeat motif, which folds back to form a bigger loop 
structure, the T-loop. TRF1 can also interact with the duplex DNA but it is not crucial for the 
interaction with telomeric substrate (Griffith et al., 1999). Other proteins of the Shelterin 
complex are the protein protection of telomeres 1 (POT1), repressor activator protein 1 
(Rap1), tripeptidyl peptidase 1 (TPP1), and TRF1-interacting nuclear factor 2 (TIN2). POT1 
is important for the formation of a smaller loop structure at the 3’ overhang, which is named 
as the D-loop, whereas Rap1, TPP1 and TIN2 interact with TRF1, TRF2 and POT1. In the 
absence of the Shelterin complex, the chromosomal ends are recognized as broken ends, thus 
leading to the activation of the DNA repair machinery (reviewed by De Lange, 2005). This 
suggests that presence of telomere repeat sequence at the end of each chromosome per se is 
not enough and requires interaction with Shelterin complex to protect the chromosomal ends. 
 
 
Fig. 1: Structure of telomeres. Schematic diagram representing the arrangement of proteins in 
the Shelterin complex at the telomere sequence, involving two loop structures, the T-loop and D-
loop (Calado and Young, 2008). 
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The biological function of these repetitive telomere motifs was initially described by H. J. 
Muller in 1938 who proposed that chromosomal ends are capped by certain terminal genes 
and that these genes are indispensable for chromosomal stability. He termed these terminal 
genes “telomeres” (Muller, 1938). Muller’s idea was further supported by Barbara 
McClintock who provided evidence that the broken chromosomal ends can fuse together, 
while the intact chromosomal termini are protected against such fusions (McClintock, 1941, 
1942). Therefore, telomeres perform a critical function to preserve the integrity of the 
genomic DNA by protecting the chromosomes from end-to-end fusions (reviewed by 
O'sullivan and Karlseder, 2010). However, whenever a eukaryotic cell divides, these 
protective chromosomal ends get truncated and are not completely replicated due to the so-
called ‘end replication problem’ of DNA polymerase enzyme. Since the DNA polymerase 
enzyme is a unidirectional enzyme, it cannot replicate few bases at the 3’ template with each 
replicative cycle, which results in a loss of nucleotides at the terminal telomere repeats (Levy 
et al., 1992) (Fig. 2).  
 
  
Fig. 2: End replication problem. 
Scheme explaining telomere 
shortening by the end replication 
problem of DNA polymerase enzyme 
(image idea adopted from the blog 
(https://blogs.scientificamerican.com/
guest-blog/the-hallmarks-of-cancer-4-
limitless-replicative-potential/) 
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Though telomeres get mainly shortened as a result of numerous rounds of cell division during 
lifetime, other genetic and environmental factors also contribute to the chromosomal attrition. 
Regular loss of telomere sequences has striking consequences with respect to species 
preservation and evolution since it limits cellular and organismal lifespan by inducing a state 
of permanent growth arrest in eukaryotic cells, called senescence (Shay and Wright, 2000). In 
this respect, the presence of critically short telomeres, rather than a reduction of the average 
telomere length, appears to be crucial for the initiation of replicative senescence and therefore, 
is considered as a biomarker of ageing (Hemann and Greider, 2000).  
1.1.1 Replenishment of telomeres 
The end replication problem of DNA polymerase is solved by a ribonucleoprotein complex, 
the telomerase enzyme, which is capable of de novo addition of TTAGGG(n) repeats to the 
chromosomal ends (Greider and Blackburn, 1987). Telomerase is a reverse transcriptase 
enzyme, consisting of two basic subunits in mice and humans: 1) the RNA component 
(TERC: telomerase RNA component), which serves as a template for the addition of 
telomeric repeats to the 3´ end of the chromosome; 2) a catalytic subunit (TERT: telomerase 
reverse transcriptase) which catalyzes the synthesis of the TTAGGG sequence (Fig. 3) 
(Garforth et al., 2006). Dyskerin is another protein, which interacts with TERT and is 
responsible for maintaining the stability and proper functioning of the enzyme (Cohen et al., 
2007). In most somatic cells, telomerase is expressed at very low levels, whereas it is highly 
expressed in embryonic tissue (Wright et al., 1996) and reactivated in immortal tumor cells 
(Kim et al., 1994). Telomerase is a multitasking enzyme and performs many cellular functions 
other than addition of telomere repeats (reviewed by Chiodi and Mondello, 2012). Likewise, 
it is involved in cellular survival, proliferation, gene regulation and cellular signaling. 
Thereby, the catalytic subunit TERT maintains cell survival in cancer cells and also improves 
neural cell survival by inhibiting apoptotic pathways (Kang et al., 2004). Inhibition of TERT 
activity in neurons increases their vulnerability to amyloid ß-peptide-induced oxidative stress 
and mitochondrial damage (Zhu et al., 2000). Recently, TERT has been shown to tightly 
regulate NF-κB-related gene expression by forming a feed-forward loop with the RelA 
subunit of canonical NF-κB (Ghosh et al., 2012).  
Introduction 
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1.1.2 Methods to determine telomere length 
Several methods have been developed to measure relative or absolute telomere length within 
different cell types and tissues, individual chromosomes or even individual arms of 
chromosomes and isolated genomic DNA. Such methods vary in their sensitivity to identify 
the shortest telomeres, and each technique currently available has its own advantages and 
limitations. The very first tool established to measure telomere length is the terminal 
restriction fragment length analysis (TRF), which is based on classical Southern blot 
technique and allows determine the mean telomere length in a given genomic DNA sample 
from cells or tissue. TRF analysis is quite laborious and although it has certain limitations it is 
still considered as a gold standard and used to validate other methods for quantification of 
telomere lengths. Moreover, TRF requires a large amount of sample DNA and has a limited 
accuracy for telomere length measurement as it detects both telomeric and sub-telomeric 
regions. TRF analysis is also totally insensitive to detect shorter telomeres because of the low 
hybridization signal associated with them (Baird, 2005; Vera et al., 2012; Montpetit et al., 
2014).  
Other methods based on real time quantification of telomeric repeats in genomic DNA, e.g. by 
polymerase chain reaction (PCR) are also widely used, especially for population studies. 
PCR-based telomere length determination was originally developed by Cawthon in 2002, 
which again like TRF analysis provides the relative quantification of the mean TTAGGG(n) 
tract length in a given sample by assessing the ratio of telomere repeats copy number to the 
reference gene copy number (T/S ratio) (Cawthon, 2002). Unlike to the TRF analysis, this 
method is more rapid and robust, requires less amount of DNA and does not amplify sub-
telomeric regions, which makes it more accurate and reliable (Vera et al., 2012). Later on, 
different adaptations were elaborated to improve this assay. Cawthon in 2009 developed a 
multiplex assay, in which both the telomere and single copy gene were amplified in the same 
Fig. 3: Structure and function of telomerase complex. The two basic subunits TERT and TERC of 
the active telomerase enzyme. Image idea adopted from web link 
http://www.public.asu.edu/~jchen61/ChenLab/Research.html 
 
Introduction 
5 
 
well to make the measurements more precise (Cawthon, 2009). The multiplex assay again 
only permitted a relative quantification of the telomere repeats and thus did not provide 
absolute telomere length measures. This issue was resolved by introducing a standard curve 
created from serial dilutions of telomere constituting oligomers and the reference gene 
sequence, both displaying known transcript length in terms of kilobases (O'Callaghan and 
Fenech, 2011). With all these adaptations, it is possible to get relative or absolute estimates of 
telomere lengths at the single cell level. Still, the main limitation of this method is associated 
with the incompetency to measure telomeres on single arms of the chromosomes and 
therefore the incapability to estimate the percentage of very short telomeres (Vera et al., 
2012). Other methods like Flow-FISH and quantitative (Q)-FISH which rely on fluorescent in 
situ hybridization (FISH) either coupled to flow cytometry or digital imaging microscopy 
respectively, are highly sensitive and serve as specific tools for telomere length quantification 
at the level of single cells or even single chromosomes (Vera et al., 2012; Montpetit et al., 
2014). FISH methods are basically carried out using a synthetic peptide nucleic acid (PNA) 
probe , which is highly specific to the TTAGGG repeat sequence (Vera et al., 2012). Q-FISH 
can be performed on metaphase spreads of cells, interphase cells as an Interphase (I) Q-FISH 
or high throughput (HT) Q-FISH, as well as on tissue slices to achieve an absolute 
quantification of telomeres of individual chromosomes, thereby allowing the detection of 
short telomeres (Vera et al., 2012; Aida et al., 2014). On the other hand, the Flow-FISH 
method provides the average measurement of telomere length and thus again compromises the 
analysis of individual short telomeres (Vera et al., 2012; Montpetit et al., 2014). Q-FISH 
methods are not very suitable for population-based studies since it is technically demanding, 
time consuming and laborious.  
1.1.3 Factors affecting telomeres and their integrity 
Telomeres are highly conserved among all the vertebrate species (reviewed by Calado and 
Dumitriu, 2013). However, telomere length greatly varies across different species and is 
genetically determined for each species (Manning et al., 2002). In humans, the telomeric 
repeats are 10-15 kb long (Allshire et al., 1989), while in inbred laboratory mouse strains 
telomeres are 5 to 10 times longer, reaching 150 kb (Kipling and Cooke, 1990) although they 
have much shorter lifespan than humans. This observation led to the speculation that telomere 
length has no correlation with organismal lifespan (Hemann and Greider, 2000). Moreover, 
these ultra-long telomeres in inbred mouse strains are assumed to arise from the lack of 
genetic exchange and excessive cross-mating within small, inbred mouse colonies (Hemann 
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and Greider, 2000; Manning et al., 2002). In humans, telomere length exhibits great intra- and 
inter-individual variations and is affected by various factors including genetic and 
environmental variables (Vasa-Nicotera et al., 2005; Dlouha et al., 2014). In a recent study, 
Dlouha and colleagues analyzed the relative telomere length in several tissues including brain 
and peripheral blood leukocytes from human subjects with ages ranging from 29 weeks 
postnatally to 88 years. They found a great degree of intra-individual variability in the relative 
telomere length (RTL) of different tissues (Dlouha et al., 2014). Likewise, in mice the 
telomere length of different tissues was also found to be highly variable within the same 
organism (Prowse and Greider, 1995; Coviello-McLaughlin and Prowse, 1997). The 
differences in telomere lengths of different tissues within the same individual argue for a 
tissue-specific regulation of telomere lengths (Coviello-McLaughlin and Prowse, 1997). 
Likewise, the reported heritability factor for the telomere length in leucocytes ranged between 
36-82%, which shows that telomere lengths are moderately to strongly heritable (Vasa-
Nicotera et al., 2005; Andrew et al., 2006). The genetic origin and the mode of telomere 
length inheritance is still a topic of debate. Some studies reported a maternal origin and X-
linked inheritance, in terms of stronger mother-offspring correlation (Nawrot et al., 2004; 
Broer et al., 2013). On the contrary, some earlier studies showed a significant link with 
autosomal inheritance, thereby associating the telomere length with chromosome 12 and 14 
(Vasa-Nicotera et al., 2005; Andrew et al., 2006). Other studies supported a paternal mode of 
inheritance and presented a strong correlation between father-offspring telomere length 
(Nordfjäll et al., 2005; Njajou et al., 2007; Nordfjäll et al., 2010). Paternal contribution to 
telomere length inheritance was also indicated by strong correlation between grandparents-
grandchild pairs (Nordfjäll et al., 2010). Telomere lengths in human blood cells have also 
been demonstrated to be positively correlated with the paternal age at the time of the 
offspring’s birth (Unryn et al., 2005; De Meyer et al., 2007; Broer et al., 2013).  
Telomere lengths greatly vary between the two genders, with females displaying longer 
telomeres as compared with men (Nawrot et al., 2004; Mayer et al., 2006; Gardner et al., 
2014; Dalgård et al., 2015). In addition, the age-associated telomere attrition rate is faster in 
males as compared with females, which ranged between 24-25 and 16-19 bp per year for men 
and women, respectively (Nawrot et al., 2004; Nordfjäll et al., 2005; Möller et al., 2009). The 
longer telomeres in females may be at least partly attributed to the estrogen-mediated 
transcriptional regulation and activation of TERT (Misiti et al., 2000). A recent study in a rat 
model for menopause has also shown anti-ageing effects of exogenous estrogen via TERT 
activation (Cen et al., 2015). Moreover, females may also be protected against reactive 
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oxygen species (ROS)-induced telomere damage due to the scavenging effects of estrogen 
(reviewed by Aviv, 2002). 
In addition to the above-mentioned hereditary and gender-related effects, telomere length 
dynamics in humans are also shaped by an individual’s life style and many environmental 
factors. Smoking causes oxidative damage to DNA and hence increases the rate of telomere 
shortening (Song et al., 2010). Thereby, the rate of telomere shortening seems directly 
proportional to the amount of cigarettes consumed per day (Valdes et al., 2005; Song et al., 
2010). Likewise, obesity also leads to an elevated level of ROS (reviewed by Marseglia et al., 
2014) and thus might negatively influence telomere stability. Similarly, Valdes and 
colleagues showed that white blood cells from obese women displayed shorter telomeres as 
compared to non-obese ones (Valdes et al., 2005). In contrast, dietary intake of antioxidants 
like omega-3 fatty acids (Farzaneh-Far et al., 2010), vitamin C and E (Xu et al., 2009) and 
moderate levels of physical exercise (Ludlow et al., 2008) preserve the chromosomal ends. 
1.1.4 Replicative senescence and telomere integrity 
Cultured diploid cells have a finite replicative capacity and after multiple rounds of mitotic 
cell divisions, the cells reach a limit where they cannot divide anymore. This limit, where the 
mitotic activity of cells ceases and senescence is induced, is called “Hayflick limit” (Hayflick, 
1965). The underlying mechanism for the proposed Hayflick limit can be explained by the 
telomere hypothesis (Harley et al., 1992). The recurrent replication cycles in cells with low or 
no telomerase activity inevitably leads to the development of critically short and 
dysfunctional telomeres. Moreover, the shortening of chromosomal extremities with each 
round of cell replication to a certain checkpoint results in replicative arrest induced by DNA 
damage responses (Fumagalli et al., 2012). Although telomere shortening leads to replicative 
arrest, these senescent cells remain alive and perform their metabolic functions (Harley et al., 
1992). As aforementioned, telomere shortening is also promoted by oxidative stress. The 
Guanine-rich sequence of the telomere repeats increases their susceptibility and makes them 
vulnerable towards ROS, which results in a persistent damage and attrition of the telomere 
tracts (Kawanishi and Oikawa, 2004; Coluzzi et al., 2014). Moreover, short and dysfunctional 
telomeres also arise due to frailty in the telomere-associated proteins such as the Shelterin 
complex and the telomerase enzyme (O'sullivan and Karlseder, 2010). 
In conclusion, the capping of the chromosomal ends by telomeres is crucial for chromosomal 
stability and genome integrity and once the telomeres are shortened and become 
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dysfunctional, it can lead to the development of ageing-associated degenerative diseases, 
cancer and rare inherited disorders (Wu et al., 2003; Vulliamy et al., 2006; Willeit et al., 
2010). 
   The ageing and diseased brain 1.2
The brain is highly vulnerable to pathological ageing as indicated by the strong, age-related 
increase in the incidence of neurodegenerative disorders. In comparison to other organs, brain 
tissue shows a high susceptibility towards oxidative stress, caused by high levels of ROS 
production, which arise from the high metabolic rate and oxygen consumption of this organ. 
ROS along with the trace elements copper and iron modify biological molecules like lipids, 
proteins and nucleic acids including the mitochondrial and telomeric DNA, which can result 
in cellular damage (Floyd and Carney, 1992; Hollensworth et al., 2000; Jeng et al., 2013; 
Coluzzi et al., 2014). There is substantial evidence pointing to protein damage by ROS, 
including breakdown of important metabolic enzymes essential for physiological brain 
function (Smith et al., 1991). The prevalence of non-dividing neurons, which cannot 
compensate DNA damage, e.g. by replication-dependent homologous recombination, leads to 
further accumulation of cellular damage, entailing inflammation, enhanced astrocytic 
reactivity, calcium dysregulation and mitochondrial dysfunction, factors which ultimately will 
impair normal brain function with ageing (reviewed by Sibille, 2013). 
Changes in the expression levels of specific sets of genes, related to certain cell types and 
biological processes in the ageing brain, have been reported in many studies. Gene expression 
in the brain is also modulated by age-associated DNA damage, mediated, e.g., by increased 
oxidative stress. Transcriptional profiling of human frontal cortical tissue from individual 
subjects with ages ranging from 26 to 106 years displayed reduction in the expression levels 
of genes involved in synaptic and mitochondrial functions, transport of proteins, cellular 
stress management, DNA repair and antioxidant mechanisms at ages beyond 40 years (Lu et 
al., 2004). Moreover, these genes down-regulated with ageing displayed striking DNA 
damage in their promotor regions, which was partially mediated by oxidative stress as 
assessed by in vitro studies using human cortical neurons (Lu et al., 2004). In contrast, glial 
genes involved in inflammatory pathways and cellular defense mechanisms  often appear up-
regulated (Erraji-Benchekroun et al., 2005). In conclusion, such studies suggest that lack of 
genome integrity, including telomeric DNA alterations, is one of the hallmarks of brain 
ageing. 
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1.2.1 Telomere length dynamics in the ageing and diseased brain 
Telomere attrition has been strongly implicated in the senescent-related ageing process of 
somatic cells. Therefore, progressive telomere shortening up to a critical length is assumed to 
drive the cell into replicative senescence, and has been regarded as a biomarker for ageing. In 
spite of increasing evidence concerning the role of telomere integrity in genome stability in 
general and in the healthy ageing process of organs with high cell turnover rate, the 
importance of telomere length dynamics for the ageing process itself and development of age-
related CNS pathologies remains largely unaddressed. Accordingly, there are only few reports 
available in this context (Takubo et al., 2002; Takubo et al., 2010).   
The fact that the terminally differentiated brain predominantly consists of cell types that are 
thought to have only moderate (glial) or even no (neuronal) cell cycle activity could partially 
explain the lack of knowledge currently available on the contribution of telomeres to  
neurosenescence. According to the prevailing notion, glial cells are the only cell types in the 
brain retaining a lifelong moderate proliferative potential, whereas neurons are believed to be 
devoid of cell cycle activity as soon as they become terminally differentiated (Nakamura et 
al., 2007). However, the two groups of K. Herrup and T. Arendt  have recently provided 
convincing evidence for a continuous and active suppression of the cell cycle machinery in 
quiescent neurons (Herrup and Yang, 2007; Arendt, 2012). Loss of control on cell cycle 
activity in neurons might end up in an aberrant cell cycle re-entry and related neuronal 
apoptosis-like death (Arendt and Brückner, 2007; Zhang and Herrup, 2011). Moreover, up to 
10-20% of the quiescent cortical neurons in the healthy ageing brain and in brains from 
patients with Alzheimer’s disease show an altered DNA content, which thus may serve as a 
potential marker for cell cycle re-entry (Mosch et al., 2007; Fischer et al., 2012). Furthermore, 
such an atypical cell cycle activity and concomitant increase in DNA content have also been 
linked to mediate development of Alzheimer dementia (Arendt and Brückner, 2007; McShea 
et al., 2007; Arendt, 2012) and other neurodegenerative disorders like Parkinson’s disease 
(Höglinger et al., 2007) and amyotrophic lateral sclerosis (Ranganathan and Bowser, 2003). 
Aberrant, unscheduled cell cycle activity in neurons has been shown to remain abortive in 
most cases and thus is distinct from a true cell division cycle. The impact of such an abortive 
cell cycle activity on telomere length is still uninvestigated. 
In spite of the common notion that brain neural cells are mostly postmitotic and therefore do 
not undergo any telomere attrition, there are few studies which report about telomere 
instability in the mammalian brain. In an early study, Coviello-McLaughlin and Prowse 
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(1995) described a remarkable telomere length reduction in the brain of mice. Similarly, 
Flanary and Streit also demonstrated telomere shortening in the cortex and cerebellum of the 
rat brain up to the age of 5 months, with cortex harboring the shortest telomeres (Flanary and 
Streit, 2003). Microglia, being capable of mitotic cell division, were thought to be the only 
putative causal agent responsible for the reduction in average telomere lengths (Flanary and 
Streit, 2003). However, their findings are contradictory to a contemporary report showing that 
telomere length in male and female rat brain tissue remains unchanged up to an age of 15 
months, whereas telomere length in more replicative tissues such as pancreas, liver, lungs and 
kidneys was found to be reduced at this age as compared to the neonates (21 days) and young 
rats (3 months) (Cherif et al., 2003). Moreover, at 15 months of age, no increment was 
observed in the percentage of very short telomeres in brain tissue, though the moiety of short 
telomeres was augmented in other tissues (Cherif et al., 2003). Studies on brain samples from 
human subjects with ages ranging from 0-104 years also suggested that cerebral cortex, like 
non-replicative myocardium, preserves the telomeres during chronological ageing (Takubo et 
al., 2002; Takubo et al., 2010). Interestingly, telomeres from human cerebral white and gray 
matter showed marginal decline in lengths until the age of 70-79 years, whereas specimens 
from later age categories ranging from 80 to 100 years presented longer telomeres, with 
centenarians displaying the longest telomeres. Such observations suggested that individuals 
with longer life span may retain constitutively longer telomeres from their birth onwards 
(Nakamura et al., 2007). Additionally, under physiological conditions, gray matter comprising 
in particular neuronal nuclei devoid of cell cycle activity presented significantly longer 
telomeres than the white matter, which encompasses oligodendrocytes with preserved 
proliferative capability (Nakamura et al., 2007). Strikingly, centenarians with such prevailing 
longer telomeres presented lower rate of cancer incidence (Nakamura et al., 2007). The 
conclusion that individuals with longer life span might retain constitutively longer telomeres 
from their birth is noteworthy and requires further investigations, including tissues that retain 
telomere lengths independently of age.  
Changes in both telomere length and telomerase expression and activity have been associated 
with many neurodegenerative and psychiatric disorders. For instance, reduced levels of 
telomerase activity and high oxidative stress accompanied by increased telomere attrition are 
significantly linked to acute and chronic psychological stress (Epel et al., 2004). Moreover, 
telomere lengths in blood samples of patients suffering from various neurodegenerative 
disorders like Alzheimer disease (AD) (Panossian et al., 2003; Thomas et al., 2008; Kota et 
al., 2014) and psychiatric disorders like schizophrenia were significantly shorter than those of 
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healthy controls (Kao et al., 2008).  Lukens and colleagues found a direct correlation between 
the telomere lengths of blood leucocytes and cerebellar tissue in AD patients (Lukens et al., 
2009). However, in the intra-tissue comparison, telomere length in cerebellum from AD 
patients remained unaltered as compared to respective controls and thus appeared not to be 
involved in the disease-associated telomere shortening process. Likewise, no telomere 
attrition as compared to healthy controls was observed, e.g., in cerebellar gray matter of 
patients with bipolar disorders and schizophrenia (Zhang et al., 2010) and in cortical and 
cerebellar gray matter of patients suffering from major depressive disorders (MDD) (Zhang et 
al., 2010; Verhoeven et al., 2014). Thus, telomere shortening in blood samples of patients 
with neurodegenerative and psychiatric disorders are likely to be unrelated to brain telomere 
length and might not serve as an indicator of telomere shortening in this organ (Lukens et al., 
2009; Zhang et al., 2010). In another study using Q-FISH, a significant decrement in telomere 
length of hippocampal neurons from AD patients was observed as compared with the controls 
(Franco et al., 2006). In contrast, Thomas and colleagues found a significant AD-associated 
increment in telomere length of up to 49% using a polymerase chain reaction-based method 
(Thomas et al., 2008). The contradictory results described for telomere length quantification 
in AD patients might arise from the high technical variability found across the studies. This 
issue therefore requires further analysis.  
1.2.2 Telomeres and Amyotrophic lateral sclerosis (ALS) 
Amyotrophic lateral sclerosis (ALS) is the most frequent age-associated neurodegenerative 
disorders of the motor system, characterized by the irreversible and progressive loss of motor 
neurons located in the cerebral cortex, brain stem and along the ventral horns of the spinal 
cord (Kiernan et al., 2011; Brettschneider et al., 2013). The disease usually manifests with the 
development of paralyses, involving skeletal and respiratory muscles (reviewed by D’Amico 
et al., 2013) starting at an average age of 65 years (Turner et al., 2012), with peak incidences 
being found between 50 and 75 years of age (van Es et al., 2017). ALS is characterized by a 
rapid clinical progression, leading to the demise of the patients within 20-48 months after the 
onset of symptoms (Paulukonis et al., 2015). The underlying cellular, biochemical and 
molecular pathomechanisms are numerous and complex, and incompletely understood. 
However, many studies have shown the association between oxidative stress levels and 
malfunction of cellular processes leading to motor neuron degeneration in ALS (reviewed by 
D’Amico et al., 2013). Likewise, an increment in the protein nitration at tyrosine residues, 
which converts it to 3-nitrotyrosine and serves as a biomarker for protein translational 
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modification caused by oxidative stress, was found in both sporadic and familial ALS patients 
carrying SOD1 mutations (Beal et al., 1997). Moreover, a study carried out in hSOD1
G93A
 
transgenic animals overexpressing the mutant human SOD1 gene showed an increased 
oxidative damage to proteins isolated from the spinal cord tissue (Poon et al., 2005). 
Therefore, ALS pathomechanisms might also involve ROS-mediated telomere attrition and 
thus add up to the neurodegenerative process, though this has not been elucidated yet. At 
present, there are few studies, which show a link between telomeres, telomerase enzyme and 
ALS disease entities. ALS patients displayed shorter telomere lengths in their blood 
leucocytes as compared with respective healthy controls, and showed reduced levels of TERT 
expression, as assessed in leucocytes and postmortem spinal cord tissue (De Felice et al., 
2014). Recently, shorter telomere length arising from the absence of telomerase activity in 
double transgenic mTerc
-/-
;SOD1
G93A
 mice, a mouse model for ALS-like pathology with short 
telomeres, was associated with earlier disease onset and reduced life expectancy (Linkus et 
al., 2016). Interestingly, the induction of telomerase enzyme in hSOD1
G93A
 mutant mice by 
the pharmacological compound AGS-499 was shown to delay ALS onset and progression by 
improving the survival of spinal motor neurons by up to 60% (Eitan et al., 2012). In spite of 
these findings, region-specific changes in telomere length and telomerase activity and the 
possible influence on ALS disease manifestation are not yet clear. In particular, a study 
specifically assessing telomere length at early and late disease stages does not yet exist.  
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2 AIMS OF THE STUDY 
Several studies have shown that changes in telomere length contribute to DNA damage 
response, chromosomal instability, cellular senescence and apoptosis, and that they correlate 
with disease- and ageing-associated pathologies (Tümpel and Rudolph, 2012). One open 
question is whether telomeres in postmitotic cells of the CNS, in particular neurons, are also 
subjected to age-related telomere attrition. This issue is highly relevant in order to define 
factors involved in the increased prevalence of neurodegenerative disorders in the human 
ageing population (Rolyan et al., 2011).  
Telomere length is tightly regulated by the enzyme telomerase, which consists of a reverse 
transcriptase (TERT) and a RNA component (TERC). The telomerase enzyme also performs 
many non-canonical functions and is involved in several regulatory pathways for cell survival, 
gene transcription, cell signaling and cellular restitution mechanisms (reviewed by Chiodi and 
Mondello, 2012). At the molecular level, telomerase regulates NF-κB-dependent transcription 
and, reciprocally, NF-κB interacts with TERT via a feed forward loop (Ghosh et al., 2012). In 
addition, the neuroprotective role of telomerase has been evidenced by the induction of 
telomerase enzyme in a murine model of ALS, showing improved neuronal survival and 
delayed disease onset and progression (Eitan et al., 2012). The importance of telomere-
dependent and telomere-independent telomerase functions and TERT transcriptional 
regulation in the ageing CNS are still undefined. Moreover, though telomere integrity and 
telomerase activity have been linked to ALS-like pathology, region-specific telomere length 
dynamics and telomerase activity in brain and spinal cord, and their possible contribution to 
the disease pathogenesis and progression are not yet been fully explored. Therefore, our 
project aimed to elucidate: 
i. Age-associated telomere length dynamics in cortical neural cells of the mouse brain 
ii. Telomere length alterations in the CNS as a function of disease progression in the 
murine hSOD1
G93A
 strain, an experimental model of ALS pathology 
iii. Changes in telomerase activity in different brain regions in association with CNS 
ageing and ALS-like pathology  
iv. A possible role of NF-κB subunits in telomerase function in the aged and diseased 
brain 
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In particular, we wanted to determine: 
- whether telomere length in the ageing brain is influenced in a cell cycle-dependent 
and -independent manner 
- whether inbreeding, which is known to be a strong genetic factor that influences 
telomere length in mice, also has an impact on telomeres in the ageing brain. For 
this, studies were performed in a standard C57BL/6 strain and compared with a 
derivative sub-strain devoid of genetic refreshment for at least 90 generations 
- whether telomere length in the CNS of the hSOD1G93A strain is altered with 
disease progression 
- whether TERT activity is influenced by CNS ageing and during the course of 
ALS-related disease progression, the latter being assumed to underlie a precocious 
ageing process   
- whether the activity of NF-κB, as a master regulator of age-related genetic 
reprogramming, correlates with TERT activity and contributes to influence 
telomere length in the geriatric brain 
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3 MATERIALS AND METHODS 
 Animals 3.1
To study the impact of physiological ageing on brain telomere length dynamics and 
telomerase activity, male C57BL/6 mice at an age of 3 months and 24-28 months from two 
distinct colonies were used. One colony of the C57BL/6 mice, named here as B6Je, were kept 
under hermetic inbreeding conditions without any genetic refreshment for at least 90 
generations; the second colony, denoted here as B6J, was cross-bred under regular genetic 
refreshment for at least 50 generations. Likewise, mutant hSOD1 mice (B6.Cg-Tg 
(SOD1*G93A)1GurJ, denoted as hSOD1
G93A
) were chosen to evaluate the influence of ALS-
like neurodegenerative pathology on relative telomere lengths and telomerase activity. Three 
different stages of disease progression were assessed i.e., asymptomatic (7 weeks), pre-
symptomatic (16 -17 weeks) and symptomatic stages (19 -21 weeks, clinical score 1 or 2; 
Tab. 1). Clinical scoring of mutant mice was performed daily in the animal facility at the Jena 
University Hospital, where the animals were bred and housed. Additionally, clinical 
symptoms were finally analyzed immediately before sacrificing the mice. For both, aged and 
ALS mutant animals, subcategories according to the ages of the animals were further 
specified for each set of experiment. All animals were housed in specific pathogen-free (SPF) 
conditions at the Institute of Laboratory Animal Care and Welfare (IVuT) at the Jena 
University Hospital under controlled conditions for humidity (70-80%), temperature (22-
24°C) and light/dark cycle (14 hour day / 10 hour night cycle) with food and water ad libitum. 
All animal procedures were performed in accordance with the ARRIVE guidelines and 
conformed to current EU regulations on the Protection of Animals Act with approval of the 
regional animal welfare authorities (TVA number: 02-046/14). 
3.1.1 Clinical scoring of hSOD1G93A mutant mice 
Mutant hSOD1
G93A 
mice were scored for clinical manifestation of different stages of the ALS-
like disease according to Tab. 1. Mice with clinical score 1 or 2 were assigned to the 
symptomatic group of hSOD1
G93A
 mutant mice. 
 Trans-cardial perfusion of mice 3.2
Animals were deeply anesthetized with volatile isofluran / isofluran CP and immediately 
transcardially perfused with 25 ml of ice-cold sterile PBS/TBS (5 ml/min) for 5 min prior to 
the tissue extraction in order to remove blood contaminations and avoid artifacts in the 
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downstream applications. Briefly, mice were put in a sealed glass jar containing tissue paper 
soaked in isofluran until the animal was deeply anesthetized and no longer reactive to painful 
stimuli, but with preserved residual cardiac circulation. Fore and hind limbs were fixed into a 
plastic tray with the help of tape. For continuous provision of anesthesia, a 15 ml falcon tube 
with a small isofluran-soaked pad was inverted on the nose of the pre-anesthetized animal. 
The animal was euthanized by diaphragm perforation. The abdomen was cut open with a 
sharp scissor (FST GmbH, Essen, Germany) and the heart was exposed. A small blade cut 
was made in the apex of the left ventricle and cannulated with a knob cannula. The cannula 
was arrested in the left ventricle using a fastener. Afterwards, a small cut was made into the 
right atrium to let venous blood pouring out. Then, the animal was perfused until the 
perfusion buffer was of clear aspect. The procedure was followed by decapitation and brain 
extraction for further downstream applications.  
 
 Development of neural cell isolation protocol 3.3
Though protocols for neural cell isolation from embryonic and early postnatal murine brain 
are well established, procedures available for cell purification from mature CNS are poorly 
elaborated, and require basic validation for reproducibility, efficiency and specificity. 
Therefore, in order to evaluate the telomere length dynamics from young (3 months) and aged 
(25-27 months) murine cortical tissue, a working protocol had to be established and validated, 
starting with trial and optimization of several steps already described in the literature.  
Clinical 
Score 
Clinical Manifestation 
0 
During tail suspension, mice extend the hind limbs completely away from the 
lateral midline and are able to hold this for 2 sec (repeated 2-3 times) 
1 
Signs of weakness during tail suspension like complete / incomplete failure to 
extend the hind limbs away from the lateral midline or tremor of legs 
2 
Unable to walk normally and drag part of their feet or curl the toes few times 
during locomotion 
3 
Signs of rigid paralysis as the mice are unable to do any forward motion or to 
move their joints 
4 Mice fail completely to get into upright position 
Tab. 1: Clinical scoring of hSOD1
G93A
 mutant mice. 
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3.3.1 Isolation protocol described by Guez-Barber et al. (2012) 
As first practical guideline, we applied a protocol described by Guez-Barber and colleagues in 
2012, developed for neural cell extraction from adult wild type rat brains using enzymatic 
digestion followed by a purification via a percoll gradient and subsequent FACS (Guez-
Barber et al., 2012). Accordingly, whole cortical tissue was isolated from 3 months old male 
C57BL/6 mice, incubated with accutase enzyme (Millipore, Darmstadt, Germany) for 30 min 
and triturated during the incubation. All steps were carried out at 4°C as recommended by the 
author. However, the tissue was very difficult to triturate due to the incomplete digestion by 
the enzyme. After trituration, cells were purified with a percoll gradient according to the 
author’s description, and purification rate and cellular yield were assessed by immuno-
staining with the neuronal marker NeuN (mouse monoclonal antibody, clone A60; 1:250; 
Millipore, Darmstadt, Germany). Cell nuclei were counter-stained with DAPI solution and 
examined by fluorescence microscopy. The preparation showed a lot of debris and stained 
nuclei in big tissue clumps, which confirmed incomplete tissue digestion (Fig. 4A).  
 
 
 
 
Several approaches were evaluated to improve the accutase enzyme-based protocol. First, 
instead of using both hemispheres of a brain, only a small piece of cortical tissue (30 mg) was 
digested at different incubation times (20, 30 and 40 min at 4°C). Next, DNAse was used to 
avoid cellular clumping through nucleic acid elimination from the damaged cells. 
Furthermore, an OptiPrep instead of percoll gradient (Axis Shield Diagnostics, Dundee, 
Scotland) was implemented to improve cell isolation and purification, as described by Brewer 
and Torricelli (Brewer and Torricelli, 2007). None of these approaches improved the cell 
isolation protocol substantially (Fig. 4B). Since it seemed that the problem was at the tissue 
Fig. 4: Representative photomicrographs showing the development of cortical cell isolation 
protocol used on 3 months old C57BL/6 male mice.  Isolated cells were immuno-stained with the 
neuronal marker NeuN (green) and counter-stained with the nuclear marker DAPI (blue). (A) Neural 
cell isolates following application of an accutase-based protocol described by Guez-Barber (2011). 
(B) Isolated cortical cells after application of several modifications to the same protocol as described 
in the text. N = 3, objective = 40 x magnification, scale bar = 20 µm. 
 
 
 
 
Fig. 8: Representative photomicrographs showing the development of cortical cell isolation 
protocol used on 3 o ths old C57BL/6 male mice.  Isolated cells were immuno-stained with the 
neuronal marker NeuN (green) and counter-stained with the nuclear marker DAPI (blue). (A) Neural 
cell isolates following application of an accutase-based protocol described by Guez-Barber (2011). 
(B) Isolated cortical cells after application of several modifications to the same protocol as described 
in the text. N = 3, objective = 40 x magnification, scale bar = 200µm. 
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dissociation step, and accutase enzyme was unable to digest the tissue appropriately, a 
comparative experiment was included by incubating the tissue with accutase or papain 
(Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany) enzymes at 4°C and 37°C. Nuclear 
staining with DAPI revealed that digestion with accutase resulted in higher nuclear yield, but 
at expense of nuclear integrity that appeared fragmented in many cases. In contrast, papain 
enzyme digestion led to the isolation of fewer, but morphologically intact nuclei. 
3.3.2 Isolation protocol according to Brewer and Torricelli (2007)  
In order to further improve the neural cell isolation protocol, the procedure published by 
Brewer and Torricelli was applied, with some modifications (Brewer and Torricelli, 2007). In 
a first trial, the tissue was incubated with papain at a concentration of 2 mg/ml (Sigma 
Aldrich, Taufkirchen, Germany) at different temperatures and for different time periods under 
slight agitation. For further optimization, 0.1% ovomucoid (Sigma-Aldrich Chemie GmbH, 
Taufkirchen, Germany) was used as papain inhibitor to stop the digestion process. Moreover, 
DNAse (Sigma-Aldrich, Taufkirchen, Germany) was added to all the solutions in order to 
avoid the formation of DNA clumps. However, the papain enzyme used did not work very 
well as tissue digestion was still incomplete. Therefore,  it was replaced by the same enzyme 
from a different provider as recommended by the authors in their original protocol (Brewer 
and Torricelli, 2007). Additionally, D-Trehalose was added to all the solutions applied during 
tissue digestion and disaggregation. According to the study by Saxena et al., the use of this 
sugar compound improves the yield of viable cells by 10-folds (Saxena et al., 2012). The 
Worthington alternative papain enzyme was tried at different concentrations ranging from 0.5 
mg/ml to 2 mg/ml and at different incubation times. High enzyme concentrations led to 
increased cell damage and also to higher number of cellular clumps due to DNA released 
from broken cells.  
Incubation with papain at 1 mg/ml and 37 °C for 30 min was finally selected as best working 
parameters for cortical neural cell isolation. The modified protocol yielded approximately 8 x 
10
5
 to 1.5 x 10
6
 cells, starting from 30-40 mg of cortical murine tissue. 
3.3.3 Development of an improved and reproducible cell isolation protocol 
Based on the previous experiences, focus was next set on the tissue digestion step to further 
improve cellular integrity, purity and yield. Instead of incubating the cortical tissue with the 
papain solution at 37°C in a water bath, cortical tissue was now incubated with enzyme 
solution in a glass beaker on a hot plate. Prior to papain treatment, the tissue was first digested 
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with collagenase IA at 37°C to remove the collagen matrix. Then, the tissue was further 
dissociated by sequential treatment with different papain concentrations starting with 2 
mg/ml, followed by 1 mg/ml, under very slight rotation. This gentle treatment ensured the 
loosening of the tissue layers and release of the cells with minimal harm to the cells. The 
tissue dissociation was further improved by triturating the tissue at intervals. DNAse and D-
trehalose were used in all the solutions during the process. D-trehalose was added to improve 
the cell viability and membrane integrity by stabilizing the cells under stress (Saxena et al., 
2012). The developed protocol worked equally well for young (3 months) and aged (24-30 
months) mice from both C57BL/6 colonies. 
 Isolation of cortical neural cells with newly developed protocol 3.4
A calcium-free Hibernate A medium (BrainBits LLC, Springfield, IL, U.S.A) was made as 
shown in Tab. 2. Briefly, calcium-free Hibernate A medium was supplemented with 0.5 mM 
GlutaMax (Invitrogen, Darmstadt, Germany), 132 mM D-trehalose (Sigma-Aldrich, 
Taufkirchen, Germany) and 310 IU/ml of DNAse I (Sigma-Aldrich, Taufkirchen, Germany). 
Both enzymes, collagenase IA (Sigma-Aldrich, Taufkirchen, Germany) and papain (Cell 
Systems, Troisdorf, Germany,) as well as the papain inhibitor ovomucoid (Sigma-Aldrich, 
Taufkirchen, Germany) were diluted in the above mentioned Hibernate A working solution to 
the concentrations specified below. Hibernate A without calcium and magnesium (BrainBits, 
Springfield, LLC) was used for maximum enzyme activity and tissue digestion (Brewer and 
Torricelli, 2007).  
The mouse head was placed in a 60 mm petri plate (VWR, Darmstadt, Germany) and arrested 
on an ice block. The skin around the skull was removed using sharp small scissors (FST 
GmbH, Essen, Germany). The skull bone was removed with the help of blunt forceps (FST 
GmbH, Essen, Germany) and the brain was exposed. The exposed tissue was slightly damped 
with 0.9% saline solution (Fresenius Kabi, Bad Homburg, Germany). The lepto-meninges 
were eliminated and bi-hemispherical cortices were exposed. Both cortices were made free of 
hippocampi and white matter regions and immediately processed for neural cell isolation.  
To measure telomere length dynamics in murine brain cortex, cells were isolated according to 
the method delineated in the flow diagram given in Fig. 5. Briefly, freshly isolated bi-
hemispherical cerebral cortices from young and aged murine brains were incubated with 3.0 
ml of collagenase IA (1 mg/ml) for 30 min at 37°C under gentle agitation. In the meantime, 
papain was activated at 37°C for 30 min. Following incubation in collagenase IA for 30 min, 
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cortical tissue was transferred to a small glass tube containing 3 ml of papain solution (2 
mg/ml). The solution was stirred with a magnetic stirrer and heated on a hot plate to attain a 
temperature of 37°C under slow agitation (~100 rpm) for 15 min to break cellular 
connections. To promote the release of the loosened cells from the softened tissue, cortices 
were treated sequentially with 3 ml of papain solution (1 mg/ml) under the same conditions 
(Fig. 4). Tissue was triturated 7-10 times with a smoothened fire-polished Pasteur pipette with 
0.7-0.8 mm of tip diameter to enhance the mechanical dissociation. During the first round of 
trituration, the enzyme solution was gently streamed against the tissue using a Pasteur pipette 
in order to break it into smaller pieces, which were then further triturated. After trituration, the 
solution became turbid and thick. Remaining tissue pieces were allowed to settle down. The 
supernatant was removed and put on ice in a new 15 ml falcon tube. 
 
 
Solutions Ingredients 
1 M trehalose stock 
solution 
3.78 g D-trehalose, final volume up to 10 ml with distilled water 
DNAse I stock 
solution 
15.5 mg (~31,000 U) DNAse I,4 ml sterile  Hibernate A minus 
calcium medium, aliquoted and stored at -20°C 
1% ovomucoid 
stock solution  
400 mg BSA, 400 mg ovomucoid in 25 ml sterile  Hibernate A 
minus Ccalcium medium, adjust pH adjusted to 7.4, final volume up 
to 40 ml with  Hibernate A minus calcium medium, aliquoted and 
stored at -20°C 
Hibernate A-Ca 
working solution 
25 µl Glutamax solution,  1.32 ml of 1 M trehalose stock solution, 
400 µl of DNAse I stock solution, final volume up to 10 ml with  
Hibernate A minus calcium medium 
0.1% ovomucoid 
working solution  
1.32 ml of 1 M trehalose stock solution, 400 µl of DNAse I stock 
solution, 1 ml of ovomucoid stock solution, final volume up to 10 
ml with  Hibernate A minus calcium medium 
PBS with trehalose 
1.32 ml of 1 M trehalose stock solution, final volume up to 10 ml 
with PBS 
Tab. 2: Solutions used for neural cell isolation. 
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Enzyme action was blocked afterwards with 0.1% ovomucoid. Leftovers of tissue pieces were 
again slightly agitated and mechanically dissociated in the pre-used papain solution (2 mg/ml) 
for 5-10 min until tissue dissociation was complete. Tissue lysis was blocked with equal 
volume of 0.1% ovomucoid. Following this step, tissue lysate was successively passed 
through 100 µm and 40 µm cell strainers and centrifuged at 500 x g for 5 min. The 
supernatant was removed and the pellet was re-suspended in 1 ml PBS containing 132 mM D-
trehalose. The final neural cell suspension was incubated on ice for 15 min to stabilize the 
enzymatically and mechanically isolated cells. Cells were counted in a Neubauer counting 
chamber and immediately used for Flow-FISH, or immunohistochemistry for neural cell type 
identification. 
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 Fig. 5: Flow diagram of the cortical neural cell isolation protocol. A schematic presentation of 
the steps involved in neural cell isolation from murine brain cortex. 
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 Immunocytochemistry and microscopy 3.5
To identify and characterize different cortical neural cell types isolated from young (3 
months) and aged (27 months) mice, immunocytochemistry was performed for different 
cellular markers using primary and secondary antibodies listed in Tab. 3. The cells were fixed 
with 2% PFA for 20 min at room temperature (RT) and washed twice with 1x PBS. Fixation 
was followed by incubation with 10% normal donkey serum for 3 hours at RT to block the 
non-specific binding sites. Neural cells were then incubated with rabbit anti-ßIII-tubulin 
(1:250; Sigma, Taufkirchen, Germany) to mark neurons, with rabbit anti-CA-II (1:100; H-70, 
Santa Cruz, Heidelberg, Germany) to identify oligodendrocytes, with rabbit anti-Iba1 (1:250, 
Wako, Neuss, Germany) to discriminate microglia and with rabbit anti-S100ß to label 
astrocytes (1:1000; Synaptic Systems GmbH, Göttingen, Germany).  
 
 
All the primary and secondary antisera were prepared in 10% normal donkey serum 
containing 0.3% permeabilizing Triton X-100. Incubation was continued overnight at 4°C 
under slow rotation. After incubation with primary antisera, cells were washed twice with 1x 
PBS and incubated with Alexa Fluor 488-conjugated donkey anti-rabbit IgG (H+L) secondary 
antibody diluted to 1:250 (Invitrogen, Darmstadt, Germany) for 30 min at RT under slow 
rotation. Cells were then washed twice with 1x PBS and treated with a DAPI solution for 5 
min at RT to stain the nuclear DNA. Cells were again rinsed twice with 1x PBS and mounted 
on properly labelled clean glass slides. Photomicrographs were taken using a confocal laser 
Antibody Species 
Dilution 
Factor 
Catalogue 
No. 
Company 
anti-ßIII-
tubulin 
Rabbit 1:250 T2200 Sigma, Taufkirchen, Germany 
anti-CA-II Rabbit 1:100 SC-25596 Santa Cruz, Heidelberg, Germany 
anti-Iba1 Rabbit 1:250 019-19741 Wako, Neuss, Germany 
anti-S100ß Rabbit 1:1000 287003 
Synaptic Systems GmbH, 
Göttingen, Germany 
anti NeuN  Mouse 1:250 MAB377 Millipore, Darmstadt, Germany 
AF488 anti 
rabbit 
Donkey 1:250 A21206 Invitrogen, Darmstadt, Germany 
Tab. 3: Antibodies used for immunocytochemistry. 
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scanning microscopy (LSM 710 Zeiss, Jena, Germany) with a 63x oil immersion objective 
and appropriate lasers (488 nm laser for Alexa 488; 405 nm laser for DAPI). 
Digital photomicrographs of freshly stained cell preparations were taken with the fluorescent 
microscope AxioPlan 2 equipped with AxioCam HRC camera and the AxioVision Rel. 4.8 
software (Zeiss, Jena, Germany) to calculate the proportions of different neural cell types. 
Twenty images were taken from each of three preparations with a 40x objective, and assessed 
for each cellular marker by determining total DAPI-positive cell density and marker-specific 
cellular moieties from a display window of 360 x 275 µm, respectively. On average, a total of 
500 cells were analyzed to determine the age-dependent neural proportions. 
 Extraction of microglia 3.6
To specifically determine changes in the telomere lengths of cortical microglia from 
hSOD1
G93A
 mutant mice with disease progression, microglia were extracted and purified by 
using a combined strategy, starting with the neural cell isolation protocol previously 
mentioned in section 3.3, with few modifications, and followed by a percoll gradient as 
described by Njie and colleagues (Njie et al., 2012). In order to be able to process brain 
cortices and isolate neural cells from a group of 5-6 mice in a single experimental session, the 
protocol was slightly modified. Briefly, animals were perfused with an ice cold PBS one after 
the other and both cortices were extracted and added to collagenase solution in individual 
tubes and kept on ice. Incubation on ice was continued until the last animal was perfused. 
Then all the cortices were processed simultaneously according to the protocol with the 
exception that all the incubations were carried out at 37°C in a water bath under slight 
agitation intervals. Moreover, the final cell suspension was not incubated on ice, but 
processed immediately to select microglia by centrifuging the final cell suspension at 1000 x 
g for 5 min. In the meanwhile, an isotonic percoll gradient (Sigma-Aldrich, Taufkirchen, 
Germany) was prepared as indicated in Tab. 4. The isotonic percoll gradient was diluted with 
1x PBS to different percentages as mentioned in Tab. 5. The supernatant was discarded and 
the pellet was re-suspended in 6 ml of 75% percoll isotonic gradient. The cell suspension was 
equally distributed into 2 polystyrene tubes (3 ml of cell suspension in each tube). A total of 5 
ml of 35% percoll gradient was layered slowly and gradually on top of a tube containing 3 ml 
of cell suspension. At the end, 2 ml of 1x PBS were layered on the top of this gradient. The 
gradient was centrifuged at 800 x g for 45 min in a hanging bucket centrifuge with brake and 
acceleration set at 0 and 3, respectively. Afterwards, the top layer containing debris was 
discarded. A very light band containing microglia was formed at the junction of 75% and 35% 
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gradient layer. This was carefully separated (5-6 ml volume together from both tubes), 
transferred into fresh 50 ml falcon tubes and washed with 50 ml of 1 x PBS at 1000 x g for 10 
min using the same program settings. The supernatant was discarded and the pellet was re-
suspended in 1 ml of 1x PBS. The microglial suspension was transferred to a sterile 
DNAse/RNAse free tube. The microglial cell number was determined for each individual 
sample. The purity of the isolated cells was 94-95%, as it was assessed by determining the 
number and percentage of Iba1 positive cells. The cell suspension was again centrifuged at 
1000 x g for 5 min. The supernatant was carefully and completely aspirated and the microglia 
cell pellet was frozen in liquid nitrogen and stored at -80°C until the samples were further 
processed to extract the DNA. 
Tab. 4: Recipe of isotonic percoll gradient 
Volume of isotonic percoll 
gradient per brain (ml) 
Volume of 10x 
PBS (ml) 
Volume of 
percoll (ml) 
4.5 + 3.5 = 8 0.8 7.2 
 
Tab. 5: Preparation of isotonic percoll gradient with different percentages 
Percentage (%) 
of isotonic 
percoll gradient 
Volume 
required per 
brain (ml) 
Volume of 
isotonic percoll 
(ml) 
Volume of 1x 
PBS (ml) 
75% 6 4.5 1.5 
35% 10 3.5 6.5 
 
 DNA isolation from cells and tissues 3.7
DNA from the disseminated neural cells or homogenized CNS tissues was extracted using the 
NucleoSpin Tissue kit (Masherey Nagel, Düren, Germany) according to the kit’s manual, with 
slight modifications. 200,000-300,000 cells were re-suspended in a final volume of 200 µl of 
buffer T1. Then, 25 µl of proteinase K solution and 200 µl of buffer 3 were added and 
samples were incubated at 70°C for 3 hrs. Alternatively, for tissues, 180 µl of buffer T1 were 
added to 25-30 mg of brain tissue. The tissue was homogenized with a motorized pestle and 
25 µl of proteinase K were added. The tissue homogenate was vortexed and incubated 
overnight at 56°C in a pre-warmed heating block. On the next day, the tissue homogenate was 
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vortexed again and 200 µl of buffer B3 were added. The tissue homogenate was then 
vigorously vortexed and incubated at 70°C in a pre-tempered heating block for 10 min. After 
10 min, the homogenate was vortexed again and if there were some pieces remaining, the 
homogenate was centrifuged at 11,000 x g for 5 min and the supernatant was transferred to 
the new tube.  
All further steps of the protocol were identical for both, cells and tissue. 210 µl of ethanol 
were added to the samples and vortexed vigorously. Nucleospin columns were placed in the 
collection tubes and samples were applied on the columns. The samples were then centrifuged 
at 11,000 x g for 1 min. The flow-through was discarded and the columns were placed back in 
the collection tubes. Extracted DNA was washed by adding 500 µl of buffer BW and 
centrifuged for 1 min at 11,000 x g. The flow-through was again discarded. The DNA was 
washed by adding 600 µl of buffer B5 to the column and centrifuged for 1 min at 11,000 x g. 
Once again, the flow-through was discarded. Empty columns were centrifuged to dry the 
silica membrane. Columns were transferred to new sterile and labelled 1.5 ml tubes, and 50 µl 
of pre-warmed buffer BE (elution buffer) were added to the nucleospin column to elute the 
genomic DNA. Samples were incubated at RT for 2 min and centrifuged at 11,000 x g for 2 
min. Quantification and purity determination of DNA was performed by spectrophotometry 
using a Nanodrop 2000/2000C device (ThermoFisher Scientific, Darmstadt, Germany). A 
ratio of absorbance of ~1.8 or higher at 260 nm/280 nm indicates the purity of the DNA and 
reflects that samples are free of proteins or other contaminants. For telomere length 
measurement by qPCR, samples were diluted to a concentration of 4 ng/µl. The stocks and 
dilutions were stored at 4°C.  
3.7.1 Agarose gel electrophoresis 
To further confirm the integrity of the extracted DNA, agarose gel electrophoresis was 
performed. To run genomic DNA, 0.8-1% (w/v) agarose gel (ThermoFisher Scientific, 
Darmstadt, Germany) was prepared in 1x TAE buffer (Tab. 6). The agarose gel was heated up 
in a microwave oven until it boiled and was completely dissolved into a clear transparent 
solution. The agarose gel was allowed to cool down to 60-70°C and ethidium bromide 
(Sigma-Aldrich, Taufkirchen, Germany) was added to a final concentration of 0.5 µg/ml from 
a stock of 10 mg/ml (5 µl stock/100ml gel) in order to stain the DNA. A comb was inserted 
carefully into the gel casting chamber. The agarose gel solution was poured into the gel 
casting tray and allowed to set and polymerize at least for 30 min. The polymerized gel was 
placed in the gel tank, which was filled with 1x TAE buffer. To track and visualize DNA 
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during the gel electrophoresis, 2 µl of 6 x DNA loading dye solution (ThermoFisher 
Scientific, Darmstadt, Germany) was mixed with 10 µl of DNA samples. Then, 10 µl of this 
mix were loaded into the sample wells. 100 bp or 1 Kb DNA ladders were also loaded as a 
reference size marker. The gel was monitored and run at 80-100 V until the loading dye 
reached 75% of the gel length. Afterwards, integrity of the DNA was visualized in 
SYNGENE G:BOX gel documentation system  (VWR, Darmstadt, Germany) equipped with 
GeneSnap software version 7.09 (SYNGENE, Cambridge, UK).  
Tab. 6: Recipe of buffers 
Buffer Ingredients 
50x TAE 
Tris base = 242 g 
Glacial acetic acid = 57.1 ml 
EDTA = 18.6 gm 
Distilled water = up to 1 L 
1x TAE 
50X TAE = 20 ml 
Distilled water = 980 ml 
   Gene expression analysis 3.8
3.8.1 RNA isolation from cortical tissue 
In order to assess gene expressions, the RNA was isolated from the brain cortices of young (3 
months) and aged (25-28 months) mice using QIAzol lysis reagent (QIAGEN, Hilden, 
Germany) according to the manufacturer’s instructions. Briefly, the tissue was homogenized 
in 1200 µl of QIAzol lysis reagent for 30-45 sec using an Ultra-Turrax homogenizer (IKA 
Labortechnik, Staufen, Germany) and then incubated for 5 min at RT. Afterwards, 240 µl of 
chloroform (Sigma-Aldrich, Taufkirchen, Germany) were added and vortexed vigorously. 
The tissue homogenate was incubated for 3 min at RT and then centrifuged at 12000 x g for 
20 min at 4°C. Centrifugation resulted into 3 phases. The upper transparent aqueous phase 
containing RNA was transferred to a sterile tube containing a 1.1-fold phase volume of ice 
cold isopropanol (Roth, Karlsruhe, Germany), and a 0.16-fold phase volume of 2M sodium 
acetate (pH = 4) (Sigma-Aldrich, Taufkirchen, Germany). The contents were mixed by 
shaking and incubated for 15 min at RT. Following incubation, the samples were again 
centrifuged at 12000 x g for 15 min at 4°C. The supernatant was carefully aspirated and 
discarded. The RNA pellet was washed twice with 75% ethanol and centrifuged at 7600 x g 
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for 5 min at 4°C. The RNA pellet was then air-dried and dissolved in 40 µl of nuclease-free 
water at 65°C for 5 min. Total RNA was quantified by spectrophotometry using a NanoDrop 
device (NanoDrop 2000c, Peqlab, Erlangen, Germany). The purity of the RNA samples was 
determined by the ratio of absorbance at 260 nm and 280 nm. The ratio of ~2.0 excludes the 
presence of relevant contaminants. For cDNA synthesis, RNA was diluted to 100 ng/µl and 
stored at -80°C.  
3.8.2 cDNA synthesis 
RNA was reversely transcribed to cDNA using the RevertAid First Strand cDNA Synthesis 
Kit (Life Technologies, Darmstadt, Germany) according to the manufacturer’s instructions. 
Master Mix 1 and 2 were made as follows: 
Mix 1     Mix 2 
0.6 µl of oligo (dt) 18 primer   2.0 µl of 5x reaction buffer 
0.5 µl of random hexamer primer 1.0 µl 0f 10 mM dNTPs   
5.0 µl of RNA sample   0.5 µl RibolLock RNAse Inhibitor (20 U/µl)  
0.5 µl of RevertAid Reverse Transcriptase (200 U/µl) 
Mix 1 containing the sample was incubated in a thermal cycler at 65°C for 5 min. Then, 4 µl 
of Mix 2 were added to Mix 1 to reversely transcribe the cDNA in a thermal cycler according 
to the following program: 
Cycling Profile 
Temperature Time 
25°C 5 min 
42°C 60 min 
70°C 5 min 
4°C ∞ 
 
The cDNA was diluted with nuclease free water and adjusted to a final concentration of 5 
ng/µl. 
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3.8.3 Real time PCR for analysis of RelA and c-Rel gene expression 
In order to quantify the expression of NF-kB RelA and c-Rel in murine brain cortex, a one-step 
real-time qPCR was performed using Brillant II SYBR Green qPCR kit (Agilent 
Technologies, Frankfurt, Germany). To amplify only the genes of interest and to avoid 
genomic DNA amplification, primer pairs (Tab. 7) were designed to cover exon-exon 
boundaries. All the samples were run in technical duplicates from 5-6 biological replicates in 
each group.  
The PCR reaction had the following composition: 
10 µl of Brillant II SYBR Green qPCR Master Mix 
2.5 µl of forward primer (2 µM) 
2.5 µl of reverse primer (2 µM) 
5.0 µl of cDNA sample (5 ng/µl) 
The program used for the amplification of RelA and c-Rel cDNA is shown in Tab. 8. A 
melting curve was also generated to assess the specificity of the amplified PCR products by 
raising the temperature from 72°C to 95°C, with an increment of 0.5°C every 3 sec.  
  
  
Changes in gene expression were analyzed according to Pfaffl (Pfaffl, 2001) using delta-delta 
threshold cycle (ΔΔCt) values. Data were normalized against expression of GAPDH, a 
housekeeping gene, which was co-amplified in the same run. Data were analyzed using the 
Rotor-Gene Q Series Software 2.3.1 (Qiagen, Hilden, Germany). 
 
Gene Forward primer 5’→ 3’ Reverse primer 5’→ 3’ 
Product 
size (bp) 
 
GAPDH 
 
CAACAGCAACTCCCACTCTTC 
 
GGTCCAGGGTTTCTTACTCCTT 
 
164 
 
RelA 
 
GACCCTGACCATGGACGATC 
 
CGGCTGTTCGATGATCTCCA 
 
138 
 
c-Rel 
 
GGAAGTGTCAGGGGAGGAGA 
 
GGCTACTTGGCGGTGTACAT 
 
91 
Tab. 7: Details of the primer pairs  
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   RTL measurement 3.9
3.9.1 Flow-FISH 
In order to evaluate age-associated changes in telomere length from the murine brain, cortical 
cells were freshly isolated from male C57BL/6 mice aged 3 months and 25-27 months as 
described, and telomere length was then determined by Flow-FISH. FISH (fluorescence in 
situ hybridization) represents a highly sensitive cytogenetic procedure to assess the copy 
number of repetitive genomic DNA elements by in situ hybridization. In Flow-FISH, this 
procedure is then coupled with flow cytometry to assess the relative telomere length.  
Flow-FISH was performed on freshly isolated cortical cells by using a telomere PNA/FITC-
based kit for flow cytometry (DAKO, Hamburg, Germany) according to the guidelines 
provided in the kit, with minor addition. Briefly, freshly isolated neural cells were processed 
with hybridization solution with or without telomere peptide nucleic acid (PNA) probe/FITC.  
In order to avoid DNA clumping during the denaturation step, 30 µl of DNAse I (310 IU/ml) 
were added to all the samples. DNA was denatured by heating to 82°C in a pre-warmed 
heating block for 10 min. Denatured DNA was allowed to hybridize with telomere PNA 
probe/FITC by incubating cells in the dark overnight at RT. Following overnight incubation, 
cells were washed twice in 1x washing solution (prepared from the 10x washing solution 
provided in the kit). To determine the sample-specific and background fluorescence 
intensities, cells were incubated with 1x propidium iodide (PI) solution or PBS for at least 3 
hours at RT. The cell preparations were filtered through a 30 µm cell strainer into FACS tubes 
to get a single cell suspension and to avoid damage to the FACS device. Samples were run on 
a FACS Calibur flow cytometer (Becton Dickinson, Heidelberg, Germany). For detection of 
PNA-FITC and PI signal, FL1 and FL3 channels were selected, respectively. 
Step Temperature Time Cycles 
Initial denaturation 95°C 10 min 1 cycle 
Denaturation 95°C 15 sec 
40 cycles Annealing 60°C 30 sec 
Elongation 72°C 30 sec 
Tab. 8: Cycling profile for specific gene amplification 
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As a first step, setup parameters were defined on the flow cytometer for the equipment 
settings and optimized for detector, amplifier and threshold. The setup defined was then kept 
constant for all other Flow-FISH runs. Calibration beads and blank beads (DAKO, Hamburg, 
Germany) were run prior to the sample runs and served as an internal reference to define the 
mean fluorescence intensity (MFI). Per group, 4-8 mice were analyzed and all the samples 
were run in technical duplicates. In order to ensure that the changes in MFI for PNA-FITC are 
valid and associated to the number of telomere repeats and not an artifact due to alterations in 
the total DNA content, the relationship between MFI and cell cycle phase-specific DNA 
content of each individual sample was analyzed. This was performed by normalizing the 
PNA-FITC-H-related MFI values against sample-specific DNA content (PI-A) in a cell cycle-
dependent manner, according to the following formula:  
 
      and 
 
Linearity between PNA-FITC-related MFI value and DNA content were represented as ratios 
of 1.0 ± 0.05 -fold s.d., whereas higher or lower ratios were likely to reflect MFI changes due 
to changes in sample-specific DNA amount.  
3.9.2 Cell cycle-dependent gating strategies for neural cells 
Analysis of cell cycle phase-specific RTL was performed in a stepwise manner as shown in 
Fig. 6. First, cells were sorted into different cell cycle phases and then analyzed for MFI using 
the FCS Express 5 Plus software equipped with Multi-cycle add-on plugin (De Novo 
Software, Glendale, CA, U.S.A).  
 
 
 
(MFI (PNA-FITC-H) G
0
/G
1
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0
/G
1
) 
Fig. 6: Steps involved in analysis for relative telomere length measurement (RTL). Following 
neural cell selection, duplets were removed and the cells were identified in different cell cycle phases.  
RTL was then quantified in the selected cells according to their cell cycle status. 
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Recorded events were plotted as dot plots and overlaid with contour plots to separate and 
better discriminate the neural cells from the cellular debris and from dead cells. The neural 
cell population was characterized on the basis of the parameters ‘cell size’ and ‘granularity’ or 
‘complexity’, determined by forward light scatter (FSC) and side light scatter (SSC), 
respectively, as shown in Fig. 7A and sorted as gate “Cells”. Singlets were selected, excluding 
the doublets out by applying an exclusion gate on selected cells via plotting dot plots of PI-A 
(FL3-Area) versus PI-H (FL3-Height) channels (Fig. 7B). To make a selection of cells 
according to the cell cycle phase, the inclusion gate for cells and exclusion gate for duplets 
was combined, and events were plotted as a function of PI-based DNA content, as depicted in 
Fig. 7C. The majority of the isolated cells were resident in the G0/G1 phase. The cells, which 
showed a doubled DNA content as compared with the cells in the G0/G1 phase, were gated as 
G2 phase cells. MFI was realized for PNA probe/FITC stained and unstained samples for the 
gated cells both in the G0/G1 and G2 phase (Fig. 7D). RTL was calculated by deducting the 
MFI of PNA probe/FITC-unstained sample from MFI of PNA probe/FITC-stained sample 
(ΔMFI). 
Age-associated changes in the cell cycle proportions of isolated cortical cells were also 
determined by performing analyses on histograms showing DNA content of cortical cells 
isolated from 3 months and 25-27 months old mice. The cells were gated in different cell 
cycle phases on the basis of PI staining for DNA (Fig. 7C), and then their percentages were 
gathered for each cell cycle phase. 
. 
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3.9.3 qPCR 
In order to assess RTL in complete cortical and cervical spinal cord tissue of hSOD1
G93A
 
mutant mice, a q-PCR-based method developed by O’Callaghan and Fenech (2011) was used, 
with some modifications. This method was also applied to verify the Flow-FISH based results 
obtained for RTL in isolated cortical cells from young and aged C57BL/6 mice. 
Oligonucleotide primers against telomeric regions were utilized to amplify the telomere 
repeats in the genomic DNA in a specific sample. The 36B4 gene, which encodes an acidic 
ribosomal phosphoprotein, was used as a single copy gene to determine genome copies per 
sample. Genomic DNA samples from 5-6 biological replicates for each experimental group 
were run as technical duplicates for both, telomere repeats and the 36B4 gene in the same run. 
“No template control” was run for both the telomere and the single copy gene. Standards in 
the range of 1.56-25 ng/µl, made from serial dilutions of P1 C57BL/6 genomic DNA isolated 
Fig. 7: Cell sorting strategies for relative telomere length (RTL) measurement. Representative 
images of isolated cortical cells from a 3 months old B6Je mouse. (A) Neural cell selection. The red 
gate “Cells” indicates vital neural cortical cells. (B) Omission of doublets. The blue gate “Singlets” 
specifies the exclusion of doublets. (C) Discrimination of cells in different cell cycle phases. The vast 
majority of neural cells reside in G0/G1, while only few cells are in G2. Apoptotic cells are recognized 
as sub G0/G1 fraction. (D) Realization of cell cycle-dependent PNA-FITC MFI. Green color 
represents the MFI for G0/G1 cells and red for the cells in G2 phase. PI-A, propidium iodide area; PI-
H, propidium iodide height; PNA-FITC-H, peptide nucleic acid-fluorescein isothiocyanate height; 
SSC-H, side scatter height; FSC-H, forward scatter height.    
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from the whole brain, were also run for both primer pairs to standardize the assay. Two 
master mixes were composed for each primer pair, each displaying the following 
composition: 
12.5 µl of Light cycler 480 SybrGreen I Master (Roche, Mannheim, Germany) 
0.5 µl of forward primer (5 µM) 
0.5 µl of reverse primer (5 µM) 
5.0 µl of DNA sample (4 ng/µl) 
6.5 µl of nuclease free H2O to make the volume up to 25 µl 
The primer pairs used for both telomere repeats and the 36B4 gene (shown in Tab. 9) were 
identical to those used by O’Callaghan and Fenech (2011). 
 
Gene Primer sequence 5’→ 3’ 
Product 
size (bp) 
TeloF CGGTTTGTTTGGGTTTGGGTTTGGGTTTGGG TTTGGGTT 
>76 
TeloR GGCTTGCCTTACCCTTACCCTTACCC TTACCCTTACCCT 
36B4F ACTGGTCTAGGACCCGAGAAG 
78 
36B4R TCAATGGTGCCTCTGGAGATT 
 
The qPCR was run in a Rotor-Gene Q thermal cycler (QIAGEN, Hilden, Germany) applying 
the following cycling program: 
10 min at 90°C…. 1 cycle 
95°C for 15 sec  
60°C for 1 min 
Melting curve 
RTL was quantified in terms of the ratio of telomere repeat copy number “T” to single copy 
gene copy number “S” ( T/S ratio), The relative T/S ratio was determined by the 2-∆∆Ct method 
40 cycles 
 
40 cycles 
Tab. 9: Primer pairs used for RTL measurement. 
 
 
 
Tab. 9: Primer pairs used for RTL measurement. 
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as described by Richard M. Cawthon in 2002 (Cawthon, 2002),which determines how each 
DNA sample varies in its T/S ratio relative to the T/S ratio of a reference sample.  
   TRAP assay 3.10
3.10.1   Preparation of tissue lysate 
To evaluate age- and disease-associated changes in telomerase (TERT) activity, TERT 
activity was measured using a telomeric repeat amplification protocol (TRAP)-based kit 
(Merck Millipore, Darmstadt, Germany), which was used according to the manufacturer’s 
instructions. Briefly, animals were transcardially perfused with ice cold 1x TBS and different 
brain regions and cervical spinal cord tissue were extracted and transferred to pre-weighed 
RNAse/DNAse free tubes. The tissue was weighed and immediately froze in liquid nitrogen 
and then stored at -80°C. 
The frozen tissue was thawed on ice, and 50 µl of CHAPS lysis buffer, supplemented with 
RNAse inhibitor (ThermoFisher Scientific, Darmstadt, Germany) at a final concentration of 
100-200 IU/ml was added. Tissue was homogenized on ice using a motorized pestle. Volume 
of lysis buffer was adjusted to the wet weight of the tissue sample in order to achieve a final 
concentration of  ̴ 2 mg/µl. Tissue lysates were then incubated on ice for 30 min. Following 
incubation, samples were centrifuged at 12,000 x g for 20 min at 4°C and supernatants were 
collected. To avoid repetitive freeze-thaw cycles, all samples were aliquoted and then frozen 
at -80°C. According to the manual included in the kit, TERT activity in the tissue lysates is 
assumed to remain stable for at least one year if stored under proper conditions. 
3.10.1   Protein estimation 
In each of these final samples, total protein amount was measured with the Bradford assay. 
From each sample solution, 2 µl were pipetted to 250 µl of Bradford reagent (Bio-Rad, 
Munich, Germany) and incubated in the dark at RT for 15 min. Protein standards were 
prepared by diluting bovine serum albumin (BSA) (Sigma-Aldrich, Taufkirchen, Germany) in 
CHAPS lysis buffer within a range of 0.5-16 mg/ml. The standards were run in the same 96-
well-plate together with the samples. Sample-specific protein content was estimated 
spectrophotometrically in a TECAN microplate reader (Tecan group Ltd., Männedorf, 
Switzerland) by measuring the absorbance of all the standards and the unknown samples at 
590 nm. Protein amounts were then quantified based on the BSA standard curve. All the 
samples were then set to a final protein concentration of 500 ng/µl by dilution in CHAPS lysis 
buffer. For PCR-based TRAP assay, 1 µg of protein was used for each reaction. 
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3.10.2   TRAPeze RT telomerase activity assay 
Real time quantification of TERT activity was performed by a qPCR-based assay to quantify 
the hexameric telomeric repeats added by the catalytic subunit TERT of the telomerase 
enzyme to the artificial oligonucleotide substrate (TS) provided in the reaction mix. The 
TERT product was then amplified by the Taq polymerase enzyme using the Amplifluor 
reverse primer (RP), which has a Fluorochrome and a quencher molecule like DABSYL. The 
quencher prevents the fluorochrome from emitting fluorescence as long as it is in close 
proximity to the fluorochrome as shown in Fig. 8. Once the hairpin containing both the 
quencher and the fluorochrome is incorporated in the amplified product, it is unfolded and the 
distance between both molecules increases, abolishing the quenching effect. Thus, these 
fluorescence energy transfer (ET) primers reduce amplification artifact because they emit 
fluorescence signals only when incorporated into amplified products. The emitted 
fluorescence then directly corresponds to the TERT product. Real time quantification of 
TERT activity was performed by qPCR. The master mix contained the following ingredients: 
     5.0 µl of 5x TRAPEZE RT reaction mix 
     0.4 µl of Titanium Taq Polymerase (2 U) (TaKara, Saint-Germain-en-Laye, France) 
     2.0 µl of sample * 
 
 
The final volume of each reaction tube was adjusted to 25 µl and each sample was run in 
methodical duplicates with 5-6 animals in each group. The assay was standardized by adding 
internal positive and negative controls to each plate. TSR8 standard with a stock 
concentration of 20 amoles/µl and a sequence identical to the telomerase substrate was 
serially diluted within a range of 0.02-2.0 amoles/µl and run in each plate to assess the TERT 
activity.  
The tissue lysate was incubated at 30°C for 30 min to allow the telomerase enzyme in the 
tissue lysate to add TTAGGG repeats to the artificial TS substrate provided in the reaction 
mix. Afterwards, the telomerase activity was inactivated by a hot start PCR and TERT 
product was amplified. The PCR was run according to the following cycling profile as shown 
in Tab. 10. TERT activity was quantified in terms of real time fluorescence emission (in 
arbitrary units – a.u.) corresponding to the average Ct value of each well and condition, and 
(* All the controls, standards and samples with or without heat inactivation were added in the 
same volume) 
 
 
(* All the controls, standards and samples with or without heat inactivation were added in the 
same volume) 
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compared to the emission signal derived from the TSR8 product. Data were normalized 
against the activity of a positive cell extract sample or positive control, run in each plate. 
 
 
 
 
 
Steps Temperature Time Cycles 
Addition of telomeric repeats to TS oligonucleotide 30°C 30 min 1 
Inhibition of TERT activity 95°C  2.0 min 1 
Amplification of telomerase product and data 
acquisition 
94°C 15 sec 
45 59°C 60 sec 
45°C 10 sec 
Fig. 8: Working principle of the TRAP assay. (A) Addition of TTAGGG repeats. Telomerase 
enzyme in the tissue lysate adds telomeric repeats to TS substrate. (B) Complementary strand 
synthesis. With the help of Amplifluor RP the lagging strand is generated. (C) Amplification of the 
generated product. Telomere repeats are amplified several folds by PCR. (D) Generation of 
fluorescence signal. Accumulated unquenched fluorescent signal is quantified and referred to as TERT 
activity (modified from TRAPeze RT telomerase detection kit manual).   
Tab. 10: Cycling profile for TRAP assay. 
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 Statistical Analysis 3.11
Statistical analyses were performed using SigmaPlot (version 13.0) and IBM SPSS (version 
22) software systems. Outliers were identified and excluded by the boxplot graphical tool. 
Two-tailed Student’s t-test was applied for single pair comparison. Multiple groups were 
compared by One-way ANOVA, Two-way ANOVA or ANOVA on ranks. Holm-Šidȧk test 
was used as post hoc test. Significance levels are set as: n.s. p > 0.05, *p < 0.05, **p < 0.01 
and ***p < 0.001.  
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4 RESULTS 
 Identification and quantification of neural cell types 4.1
With the newly established cell isolation protocol we obtained around 1.6-2.5 million cells 
per murine cortex from both the young and aged categories. To validate the efficiency of the 
isolation protocol, different neural cell types and their representative proportions in the 
isolates were characterized by immunocytochemistry. Apart from comparable cellular yields, 
the isolation protocol similarly preserved the cell vitality and viability in young and aged 
isolates from both murine cohorts. Neurons and oligodendrocytes were specified as ß-III-
tubulin and CA-II positive entities, respectively (Fig. 9A and 9B). Microglial cells were 
identified by staining with Iba1, whereas astrocytes were distinguished by using S100-ß as 
marker (Fig. 9C and 9D). Different cell types were also identifiable by their morphological 
features like size, shape and cellular process-like extensions. 
 
 
 
Fig. 9: Isolated cortical neural cells from 27 months old C57BL/6 Jena (B6Je) mice identified 
by labelling with different neural cell type markers. (A) Neurons: ß-III tubulin. (B)  
Oligodendrocytes: CA-II. (C) Microglia: Iba-1. (D) Astrocytes: S-100ß. Exemplified are the LSM 
micrographs taken at 63 x objective with oil immersion. Scale bar, 5µm. 
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The relative number of each neural cell type was determined from the total number of DAPI-
positive cells within the isolate. The impact of ageing on the relative proportion of different 
cell types, isolated with our newly established protocol, was exemplified for the C57BL/6 
Jena (B6Je) sub-strain. Likewise, effects of breeding strategies on the cellular proportions 
within the isolate were determined at 3 months of age for both strains. Quantifications showed 
that the cell isolation protocol yielded reproducible data, with individual cell proportions 
being preserved across ages and sub-strains. On average, 93.31±0.54% (3 months) and 
94.19±0.46% (27 months) of the vital cells collected displayed neural identity (Fig. 10A), 
proving a similarly high efficiency rate of the protocol irrespective of the underlying tissue 
age. With respect to strain, no inter-strain differences were observed in the total content of 
individual neural cell types isolates at the age of 3 months. Altogether, a neural cellular 
identity was proven for 93.31±1.08% and 93.31±0.54% in the specimens derived from the 
B6J and B6Je colony, respectively (Fig. 10B).  
Thus, the inter-age and inter-strain comparisons confirmed that the proportions of specific cell 
types remained constant with ageing in different strains and that the isolation protocol is not 
implementing any kind of selection bias for any of the age groups or strains. Moreover, neural 
cell proportions achieved for neurons, microglia and astrocytes were in close agreement with 
the reported distribution of these cells in the adult and mature murine brain (Lawson et al., 
1990; Nedergaard et al., 2003; Herculano-Houzel et al., 2013). 
 
 
 
Fig. 10: Impact of ageing and inbreeding strategies on proportions of different cell types in 
neural cell isolates. (A) Age-dependent percentages of cells isolated from 3 versus 27 months old 
B6Je mice. (B) Strain-dependent distribution of different neural cell types obtained from 3 months 
old B6J and B6Je  mice. Neu, neurons; Mic, microglia; Oligo, oligodendrocytes; Ast, astrocytes. N = 
3 (~500 cell from each animal), Students’s t-test; n.s. p > 0.05. Data are represented as means ± 
S.E.M.     
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 Assessment of the telomere length in neural cells from murine brain  4.2
After neural cell isolation from murine brain, we were able to perform the primary aim of the 
study: to assess telomere length dynamics in the adult and aged murine brain. As a first 
approach, we focused on chromosome-specific telomere length determination by Q-FISH, a 
technique which enables to define absolute telomere length in a single cell and on each arm of 
the chromosome. In collaboration with the Laboratory of Molecular Cytogenetics at the 
Institute of Human Genetics in Jena, we started working on a Q-FISH protocol using our CNS 
cell isolates and, as a positive reference, on the ATCC-CRL 1722 murine lymphoma cell line 
(Fig. 11). 
 
 
 
 
 
Molecular cytogenetic techniques including Q-FISH have been approved for diagnostics on 
interphase nuclei with the requirement of high throughput imaging and analytical tools 
(Canela et al., 2007; Iourov et al., 2007; Vorsanova et al., 2010). In the adult and aged brain, 
most inherent cell populations are post-mitotic or display only very low replicative activity 
and thus reside in the interphase of the cell cycle. In interphase cells, chromosomes are 
narrowly clustered and the FISH-signal for telomere probe, as it normally appears like two-
paired dots for one chromosome in metaphase FISH, cannot be attributed to individual 
chromatids. Therefore, the Q-FISH protocol was not suited for telomere length analysis in 
murine brain tissue in our experimental paradigm (Fig. 11A). In contrast, in metaphase 
spreads as realized for a ATCC-CRL murine lymphoma cell line (Fig. 11C), the telomere 
ends belonging to the q- and p-arms of each of the chromosomes could easily be 
discriminated in each single cell, thus allowing quantification of the telomere length relative 
Fig. 11: Exemplified images of Q-FISH in interphase and metaphase cells. (A) A post-mitotic 
cortical neuron isolated from a 3 months old C57BL/6 (B6J) mouse following hybridization with a 
telomere specific peptide nucleic acid (PNA) probe and co-staining with the neuronal selection 
marker β-III tubulin. (B) An interphase cell and (C) a metaphase spread using the ATCC-CRL 1722 
murine lymphoma cell line. Green, PNA probe specific for the telomeric TTAGGG sequence; red, β-
III tubulin; blue, DAPI to stain nuclei. 100 x objective applying oil immersion (METASYSTEMS 
ISIS). 
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to the internal reference probe-specific Q-FISH signal intensity. In contrast, strong cluster 
formation of chromosomes and the resulting superimposition of Q-FISH signals in the 
interphase clew impeded assessment of absolute telomere length in neurons (Fig. 11A and 
11B). To overcome these obstacles, a Flow-FISH-based protocol was established for RTL 
measurement specifically in a mature neural environment. 
4.2.1 Flow-FISH-based telomere length analysis 
Fluorescent in situ hybridization was performed to label telomeres of the cortical neural cells 
and changes in RTL were then assessed by subsequent flow cytometry using a FACS-Calibur 
sorting device. 
Analyses to determine RTL were performed with the FCS Express 5 Plus software plugged in 
with a Multi-cycle add-on (De Novo Software, Glendale, CA, U.S.A). The neural cell 
population was identified and separated from the smaller cluster of cellular debris, according 
to the analysis recently described by Guez-Barber and colleagues for adult rat neural cells, as 
shown in Fig. 12A (Guez-Barber et al., 2012).The light scatter obtained (Fig. 12B) was very 
similar to the one shown by Guez-Barber and colleagues (2012) (Fig. 12A).   
Selection of the vital cell fraction was then followed by exclusion of cellular duplets to 
perform the analysis exclusively on single cells. Duplets were removed according to the 
selection parameters described by Wersto and colleagues (2001), either by plotting the gate 
parameters ‘height versus area’ or ‘width versus area’ in dot plots (Fig. 12C). Both parameters 
were tried, with better discrimination being achieved in dot plots of ‘height versus area’ in our 
set up (Fig. 12D). RTL was then indirectly determined in a cell cycle dependent manner and 
expressed as arbitrary units, with the values being referred to the mean fluorescence intensity 
(MFI) of PNA-FITC probes, which are specific for the telomere repeat sequence, and 
corrected against the background fluorescence intensity (∆MFI) as shown in Fig. 13A and 
13B. 
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4.2.2 Age-dependent changes in telomere length dynamics and telomerase activity 
4.2.2.1 Influence of ageing on the RTL of neural cortical  cells residing in G0/G1 
To quantify age-associated changes in RTL of brain telomeres isolated from C57BL/6 mice 
and their dependence on cell cycle activity, RTL of cortical neural cells were determined for 
G0/G1 and G2 phases of the cell cycle, as selected on the basis of their DNA content. Ageing 
did not influence the telomere lengths of cortical neural cells arrested in G0/G1 phase in our 
conventionally inbred mouse strain (B6J). Accordingly, a non-significant decline in ∆MFI by 
only 1.55% was observed (p = 0.857; Fig. 13A). However, neural cells in the G0/G1 phase of 
the cell cycle, which were harvested from the hermetically inbred B6Je sister colony, 
exhibited a significant reduction in RTL by aging up to 25-27 months, thereby displaying a 
reduction in the corrected MFI of the telomere specific PNA-FITC probe values by 17.64% as 
compared with the young (3 months old) counterparts (p = 0.007; Fig. 13A). As delineated in 
Fig. 10A and exemplified for B6Je mice, neurons comprise 47.93 ± 1.59% and 48.78 ± 1.25% 
of the vital cell fraction in the cortical neural cell isolates from 3 months and 25-27 months 
old mice, respectively, indicating that approximately every second cell of the vital cell 
Fig. 12: Development of the cell gating strategy. (A,B) Identification of the neural cell population 
by the light scatter on the basis of size and granularity of the cells. (A) Modified image taken from 
Guez-Barber et al. (2012) representing the light scatter for rat neural cells. (B) Cortical neural cells 
isolated from a 3 months old B6J mouse. (C) Modified image from Wersto et al. (2001) to present the 
exclusion parameters for duplets. (D) Exclusion of duplets from the cortical neural cell selection taken 
from a 3 months old B6J mouse. PI-Height, propidium iodide height; PI-Area, propidium iodide area. 
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fraction harbors a neuronal identity (p = 0.676; Fig. 10A). Moreover, the predominant fraction 
of these vital cells isolated either from the B6J (Fig. 13E) or B6Je (Fig. 13F) sister colony, 
resides in the G0/G1 phase of the cell cycle, which was proven for both young and aged 
conditions. From all these data, it is evident that the G0/G1 phase gated from neural cortical 
cell isolates comprises post-mitotic neurons up to 50% along with other neural cell types, 
inferring that these non-replicative neurons might also be susceptible to age-dependent 
telomere attrition. 
4.2.2.2 Age-associated changes in RTL observed for replicative neural cells 
In the CNS, neural cell entities that exit the G0/G1 phase and reach the G2 phase of the cell 
cycle are mainly assumed to comprise microglia and astrocytes with moderate cell cycle 
activity, possibly complemented by neurons with an unscheduled and abortive cell cycle 
activity (Yang et al., 2001; Rehen et al., 2005). Cortical neural cells derived from the B6J 
colony, which adopted features of G2 phase, as marked by a doubled DNA content in 
comparison to the G0/G1 cells, displayed no remarkable change in their RTL. This was 
reflected by a non-significant decrease of 19.85% in the ΔMFI values upon ageing up to 25 
months (p = 0.052; Fig. 13B). In contrast, in the hermetically inbred B6Je colony, neural cells 
entities that reached the G2 phase showed a drastic age-associated loss in the telomere lengths 
as depicted by a 44.72% decrease in the ∆MFI values in comparison to the young counterparts 
(p < 0.001; Fig. 13B). 
4.2.2.3 High rate of telomere shortening in hermetically inbred mice 
Generally, telomeres in inbred mice are longer than those in wild type mice (Hemann and 
Greider, 2000; Manning et al., 2002), and in this study appeared further elongated in our 
small, hermetically inbred B6Je sub-strain. In this genetically isolated colony, young mice 
showed a substantial increase in RTL compared with age-matched animals of the 
conventionally inbred B6J strain. This observation applied to cortical neural cells residing in 
G0/G1 and G2 phase of the cell cycle. Thus, regardless of the specific cell cycle phase, B6Je 
mice on average displayed significantly longer telomeres than the conventionally inbred B6J 
strain at young state. Concretely, the G0/G1 and G2 neural cell populations isolated from 
young B6Je mice exhibited a significant increment in their RTL by 23.83% and 23.16%, 
respectively, when compared with the young littermates from the B6J colony (for G0/G1: p < 
0.001; for G2: p = 0.003; Fig. 13A and 13B). 
In spite of such longer RTL at young ages in B6Je colony, the age-associated decline in RTL 
assessed for both, replicative and non-replicative neural cell populations reached similar final 
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levels in the genetically isolated as well as the conventionally inbred strain (Fig. 13A and 
13B). Henceforth, this indicates a faster rate of age-related telomere shortening in the B6Je 
sub-strain (Fig. 13A and 13B).  
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Moreover, as delineated in Fig. 10B for the 3 months age group, proportions of the different 
neural cell populations in the cortical cell isolates were very similar for both C57BL/6 
colonies, irrespective of the state of cell cycle activity, thus excluding the contribution of 
specific cell type preponderance to these remarkable inter-strain differences in RTL. Thus, the 
substantial inter-strain difference in RTL of young animals is putatively arising from strong 
inbreeding strategies. The inter-strain comparison of RTL between both replicative and non-
replicative neural cell populations also implicates that, though hermetic inbreeding is 
negatively correlated with RTL in the aging murine brain, it is positively associated with RTL 
in the young and healthy state. 
This conclusive finding about the faster rate of age-associated telomere shortening in the brain 
of the B6Je sub-strain particularly for the cells in G2 phase is depicted in Fig. 14. Fig. 14 
elucidates cell cycle-dependent telomere length dynamics for both sub-strains in terms of 
young:aged ratios. The decrement in RTL of the cells arrested in G0/G1 populations with 
ageing was moderate for B6Je mice and even absent in the B6J strain as reflected by 
young:aged RTL ratios of 1.15 ± 0.08 and 1.01 ± 0.07 (p = 0.436), respectively. In contrast, 
the rate of age-dependent decline in RTL for the neural cell populations with an active cell 
cycle was significantly faster for the B6Je cohort, displaying a ratio of 1.75 ± 0.11 in 
comparison to the B6J population (ratio: 1.38 ± 0.13) (p = 0.037; Fig. 14). 
Fig. 13: Inter-strain comparison of the age-associated changes in RTL of cortical neural cells 
isolated from both B6 cohorts. For (A) cells residing in G0/G1 and (B) cell populations in G2 phase. 
(C) Representative DNA histograms depicting an age-associated shift in cell cycle activity, as 
assessed by the PI staining of DNA. Data are exemplified for cortical cell isolates derived from B6Je 
mice at an age of 3 months and (D) 25-27 months. (E) Age-related distribution of the cortical neural 
cells in different cell cycle phases, given for the B6J and (F) B6Je colony. For (A) and (B) N = 3-8, 
Two-way ANOVA and Holm-Šidȧk post hoc test; n.s. p > 0.05, * p < 0.05, ** p < 0.01 and *** p < 
0.001. Data are represented as means ± S.E.M. For (E) N = 6-10 and for (F) N = 4-8. For E and F, p 
values are calculated by Student’s t-test; * p < 0.05, ** p < 0.01 and *** p < 0.001. Data are 
represented as means ± S.E.M.  
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4.2.2.4 Higher ∆MFI values for the replicative cells in G2 phase 
Overall higher ΔMFI values were observed for the neural cell populations in G2 phase from 
both young and aged cohorts of the two investigated C57BL/6 colonies, as compared with the 
cells residing in the G0/G1 phase, which is explained by the doubling of telomere repeat 
sequences following DNA content amplification in S phase (Fig. 15A). The increase in the 
telomere-specific ΔMFI signal for G2 populations relative to the G0/G1 values was highest for 
the young mouse cohorts irrespective of the underlying breeding conditions, which displayed 
a 94.20% - 95.93% increment in ΔMFI signal for the B6Je and B6J strains, respectively (for 
B6Je: p = 0.004; for B6J: p < 0.001; Fig. 15A). The increment in ΔMFI values for the G2 
resident cells was reduced to 30.34% in the B6Je colony and 59.51% in the B6J cohort as 
compared with the G0/G1 signal at older ages (for B6Je: p < 0.001; for B6J: p = 0.010; Fig. 
15A). 
In order to confirm that the elevated ΔMFI values of G2 cells over G0/G1 levels were due to an 
amplified DNA content, but not related to intrinsically longer telomeres, absolute telomere-
related PNA-FITC-H values were normalized against sample-specific total DNA content in 
terms of PI-A for the G0/G1 and G2 phase fractions from both underlying mouse colonies and 
from both age cohorts. The PNA-FITC-specific MFI values corrected against total DNA 
content in the young B6Je colony ranged between 0.306 ± 0.011 and 0.295 ± 0.009 for the 
cells residing in G0/G1 and G2 phase, respectively, and between 0.270 ± 0.014 and 0.261 ± 
0.009 in the aged B6Je group (Fig. 15B). In contrast, the ratios for G0/G1  and G2 phase cell 
Fig. 14: Age-associated telomere length dynamics of cortical neural cells isolated from both 
C57BL/6 colonies. RTL dynamics were calculated in terms of young-to-aged ratios for RTL values 
and expressed as a function of cell cycle activity. N = 4-9, p values are calculated by Student’s t-
test; n.s. p > 0.05 and * p < 0.05. Data are represented as means ± S.E.M.  
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moieties in the young and aged B6J mice span between 0.233 ± 0.011 - 0.223 ± 0.017 and 
0.234 ± 0.025 - 0.237 ± 0.025, respectively (Fig. 15B). The stable ratios for G0/G1 and G2 
neural cell fractions at young and aged stages from both C57BL/6 cohorts support the 
conclusion that the higher ΔMFI values of G2-phase cells originate from replicated telomere-
specific DNA due to G2-phase transition of the cells and not due to a genuine increase in 
telomere length. These calculations also validate the observation that the age-associated 
decline in ΔMFI values of both G0/G1 and G2 phase fractions in the B6Je colony originate 
from a real loss of telomere sequence and are not arising from an artifact related to a decrease 
in total DNA content. 
 
 
 
 
 
 
 
 
Fig. 15: Correlation between telomere-related DNA content and the total DNA content for 
different cell cycle phases in both young and aged cohorts of B6Je and B6J colonies. (A) ∆MFI 
values were higher in G2 than in G0/G1 phase cells, both in the young and aged groups from the two 
colonies. N = 3-8, p values are calculated by Student’s t-test; * p < 0.05, ** p < 0.01 and *** p < 
0.001. Data are represented as means ± S.E.M.  (B) Telomere-related DNA content normalized against 
total DNA content. Assessed are the ratios of absolute PNA-FITC-H signal and PI-A values for the 
G0/G1 and G2 cell moieties, respectively, which were isolated from young and aged mice of both 
colonies. N = 3-8, Data are represented as means ± S.E.M. PI-A; propidium iodide area; PNA-FITC-
H, peptide nucleic acid-fluorescein isothiocyanate height. 
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4.2.2.5 Age-associated shift in cell cycle activity  
Moreover, the impact of ageing on cell cycle activity of neural cells was determined for both 
mouse colonies. Thereby, the distribution of neural cells in different cell cycle phases was 
analyzed according to their individual DNA content, as assessed on the basis of PI staining 
and executed for both C57BL/6 cohorts (Fig. 13E and 13F). As expected due to the post-
mitotic nature of the brain, the majority of cortical cells were arrested in the G0/G1 phase in 
young mice from both, the B6J and B6Je colony (Fig. 13E and 13F). However, ageing 
resulted in a clear shift in cell cycle activity for both, the B6J and B6Je sister colonies, as 
demonstrated by an age-associated increase in the number of neural cells passing through the 
cell cycle as delineated in the DNA histograms given in Fig. 13C-D. As shown in Fig. 13E 
and 13F, the cell distribution analysis for different cell cycle phases exhibited a significant 
increase in the number of cells reaching criteria of S-, G2- and >G2- phases of the cell cycle, 
whereas the number of cells in G0/G1 phase declined significantly in aged animals from both 
strains. 
4.2.2.6 Telomere length analysis based on qPCR techniques   
Flow-FISH results were verified by measuring the RTL of cortical neural cells isolated from 
young and aged B6Je mice using the qPCR-based approach developed by Callaghan and 
Fenech (2011), with some modifications. Since RTL values cannot be assessed in a cell cycle 
phase-specific manner with the qPCR-based assay, values again reflect the average telomere 
length as determined by Flow-FISH, though without a selective gating strategy for underlying 
cell cycle phases. To allow for a comparison between both techniques, the parameters applied 
for Flow-FISH- related RTL analysis were now adjusted to qPCR criteria. Accordingly, RTL 
was measured in terms of PNA-FITC-related ∆MFI for the cells gated as “singlets”, which 
covered all the different cell cycle phases (Fig. 7B and 7C in section 3.9.2).  As delineated in 
Fig. 16A, a significant reduction in RTL was observed for cortical neural cells isolated from 
aged B6Je animals as compared with their young counterparts, when assessed by Flow-FISH 
(p < 0.001). Likewise, a considerable age-associated decline in telomere length was detected 
in isolated cortical cells when the RTL was measured by qPCR in terms of the T/S ratio 
calculated, though the effect appeared less drastic relative to the Flow-FISH results (p = 
0.016; Fig. 16B). 
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4.2.3 Strain-specific changes in TERT activity with ageing 
Telomere length is maintained by de novo addition of telomere repeats by the catalytically 
active reverse transcriptase (TERT) subunit of the enzyme telomerase, which uses an RNA 
component (TERC) as a template for the addition of tandem (TTAGGG)n repeats. Age-
associated changes in TERT activity were determined in young and aged cortical tissues from 
both C57BL/6 colonies using a qPCR-based TRAP assay and normalized against a 
standardized positive control derived from a defined cell extract (Fig. 17A). In the B6Je 
strain, TERT activity levels remained unaltered as compared to the young control group (p = 
0.638; Fig. 17A). However, TERT activity declined significantly with increasing age in the 
B6J colony (p = 0.013; Fig. 17A). Additionally, TERT activity displayed a similar level in the 
young control group from both, the B6Je and B6J colony (p = 0.634; Fig. 17A). At older ages, 
levels of TERT activity were not decreased in the B6Je colony relative to the B6J strain (p = 
0.095), which might serve as a putative balancing mechanism to compensate for the shortened 
telomeres observed in the B6Je colony.  
4.2.4 Age-dependent changes in NF-κB RelA and c-Rel gene expression 
Ghosh and colleagues recently described the existence of a mechanistic feed-forward loop 
implicating reciprocal activating interaction between TERT and the RelA subunit of NF-κB in 
a malignant environment (Ghosh et al., 2012). In light of these findings, we analyzed relative 
mRNA expression of the NF-κB subunits RelA and c-Rel in cortical tissue from B6Je and B6J 
Fig. 16: Comparative analysis of telomere length alterations as assessed by Flow-FISH and by 
qPCR. (A) RTL measured as PNA-FITC-related ∆MFI for all cell cycle phases. (B) Relative T/S ratio 
measured by qPCR and corrected against a 4 months old control group. N = 3-4, Student’s t-test; * p < 
0.05, ** p < 0.01 and *** p < 0.001. Data are represented as means ± S.E.M. 
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cohorts in young and aged groups from both strains. Gene expression for each NF-κB subunit 
was corrected against the housekeeping gene Gapdh and represented as fold changes in 
transcript levels relative to young mice. 
In line with the interaction between NF-κB RelA subunit and TERT established for a 
malignant environment, a significant up-regulation in the transcript levels of NF-κB RelA was 
found in aged B6Je mice relative to their young counterparts (p < 0.001). On the contrary, no 
age-associated changes in NF-κB RelA gene expression were observed in the B6J colony (p = 
0.403; Fig. 17B). Moreover, NF-κB RelA gene expression levels in aged B6Je mice were also 
considerably higher than in aged B6J mice (p < 0.001; Fig. 17B). However, c-Rel, a 
heterodimer partner of RelA, for which a direct interaction with TERT is not yet described, 
showed no age-associated up-regulation in expression levels in the B6Je colony. In contrast, 
c-Rel gene expression displayed a substantial decrease with ageing in the B6J colony (p = 
0.001; Fig. 17B). Moreover, expression levels of c-Rel appeared to be significantly lower in 
B6J mice as compared with B6Je mice (p = 0.001; Fig. 17B).  
 
 
 
 
 
Fig. 17: Age-associated changes in the TERT activity and relative RelA and c-Rel mRNA 
expression levels in the murine cortex derived from B6Je and B6J mice. (A) Normalized TERT 
activity as a function of age. N = 5-6, Two-way ANOVA and Holm-Šidȧk post hoc test; n.s. p > 0.05 
and * p < 0.05. Data are represented as means ± S.E.M. (B) Age-associated changes in the relative 
mRNA expression levels of canonical NF-κB RelA and c-Rel subunits, given in terms of aged:young 
ratios. N = 5-6, Two-way ANOVA and Tukey post hoc test; n.s. p > 0.05, * p < 0.05, ** p < 0.01 and 
*** p < 0.001. Data are represented as means ± S.E.M.  
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 Changes in RTL with disease progression in the murine ALS-like 4.3
model 
4.3.1 RTL in disease susceptible cortex and spinal cord  
In order to examine possible changes occurring in the telomere length of CNS tissue during 
the course of a neurodegenerative disease, hSOD1
G93A
 mutant mice, which serve as an 
established mouse model for ALS-like pathology, were used. The changes in RTL were 
investigated as a function of disease progression by means of the qPCR-based method already 
described and were specified for different disease-vulnerable CNS regions such as the 
cerebral cortex and, in particular,  the spinal cord, which harbor primary and secondary motor 
neurons, respectively, and are strongly affected by the ALS pathology. For spinal cord 
analyses, the cervical segment was preferred since more distal regions are subjected to rapid 
motor neuron loss and apoptotic degeneration. 
At the pre-symptomatic stage of the disease, no significant changes in the RTL were observed 
for the cortex and cervical spinal cord with respect to the control situation (for cortex: p = 
0.656; for spinal cord: p = 0.987; Fig. 18). In contrast, a considerable increment in RTL was 
found for cortical tissue with disease progression, as compared with control animals (p = 
0.026). Likewise, at the advanced stage of the disease, telomeres assessed in the cervical 
spinal cord tissue also showed a significant apparent elongation in comparison to the pre-
symptomatic stage (p = 0.014), as well as relative to the healthy control situation (p = 0.003; 
Fig. 18). 
 
 
 
Fig. 18: Dynamics of RTL in hSOD1
G93A
 transgenic mice with disease progression. RTL assessed 
by a qPCR-based method for cortex (Cx) and cervical spinal cord (SC) derived from male hSOD1
G93A
 
transgenic mice. RTL was analyzed at pre-symptomatic (PS) and symptomatic (S) disease stages and 
compared to RTL in respective healthy control tissues (C). N = 6, Two-way ANOVA; n.s. p > 0.05, * 
p < 0.05, ** p < 0.01 and *** p < 0.001. Data are represented as means ± S.E.M. 
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4.3.2 RTL in microglia 
Since telomeres of both, cortex and cervical spinal cord tissue appeared to be longer at the 
advanced disease stage (Fig. 18), it raised the question about the cell type involved in the 
apparent change in RTL. A previous study by Linkus and colleagues found a tendency 
towards longer telomeres in microglia from the hippocampus of ALS patients relative to 
controls. However, they did not observe any alteration in the telomeres of neurons and 
astrocytes (Linkus et al., 2016). Though performed in human samples, their data provided a 
good reference point to set out and quantify RTL in purified microglia isolated from the 
cortex of the severely diseased hSOD1
G93A
 transgenic mice and in age-matched C57BL/6 
control animals. Since RTL was found unchanged in the pre-symptomatic stage of the disease 
(Fig. 18), studies in microglia were restricted to the severe disease state. However, in our 
study, no elongation in RTL was observed in cortical microglia isolated at late disease stage 
(P = 0.406; Fig. 19). This ruled out microglia as the causal cell population responsible for the 
apparent increase in the RTL associated with severity of ALS disease.  
 
 
4.3.3 Region-specific changes in TERT activity with ALS disease progression 
Using a qPCR-based TRAP assay, TERT activity was determined in different brain regions 
and in the cervical spinal cord of hSOD1
G93A
 transgenic mice at different stages of the 
disease. The region-specific TERT activity at pre-symptomatic (16-17 weeks) and 
symptomatic (19-21 weeks, clinical score 1 or 2) stages of the disease was normalized against 
values obtained at asymptomatic stage (6-7 weeks) for each corresponding region, and 
presented as arbitrary units (a.u.). 
All brain regions examined displayed a similar trend towards an overall reduction in TERT 
activity at the symptomatic disease stage as compared with the asymptomatic control level 
Fig. 19: Microglial telomere length. RTL was assessed in purified microglia isolated from the brain 
cortex (Cx) of male hSOD1
G93A
 mice at symptomatic (S) disease stage and compared to control values 
(C). N = 5-6, Student’s t-test; n.s. p > 0.05. Data are represented as means ± S.E.M. 
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(Fig. 20A, B and C). The cortical region from hSOD1
G93A
 transgenic mice displayed a 
remarkable reduction in TERT activity with disease progression when compared with 
asymptomatic control levels (for presymptomatic stage: p = 0.014; for symptomatic stage: p = 
0.022; Fig. 20A). In contrast, the cerebellum, which is less involved in the disease process, 
showed only a trend towards reduction at later disease stages (Fig. 20B). Hippocampus, a 
region which is involved in replicative cell renewal and cell cycle activity, presented a 
progressive decline in TERT activity at the presymptomatic stage (p = 0.008) and 
symptomatic stage (p = 0.796) relative to the control levels (Fig. 20C). In contrast, the 
cervical spinal cord tissue showed an up-regulation in the enzyme activity at the pre-
symptomatic stage, relative to asymptomatic controls (p = 0.036), but exhibited a 
nonsignificant decline in enzyme activity along with further disease progression (p = 0.238; 
Fig. 20D). 
 
 
 
Fig. 20: TERT activity in different CNS regions as a function of disease progression. TERT 
activity in (A) cortex (C), (B) cerebellum (Ce), (C) hippocampus (H) and (D) cervical spinal cord (SC) 
tissue at asymptomatic (AS), pre-symptomatic (PS) and symptomatic (S) disease stages normalized 
against the asymptomatic group. N = 5-6; One way ANOVA applying Holm Šidȧk formula as post 
hoc test for A, B, D and ANOVA on rank for C; n.s. p > 0.05, * p < 0.05, ** p < 0.01 and *** p < 
0.001. Data represented as means ± S.E.M.  
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5 DISCUSSION  
Telomeres, the protective chromosomal caps, are shortened with each replicative cycle and 
are thus regarded as mitotic clocks, which limit replicative capacity of somatic cell. Hence, 
telomere ends are crucial for genome integrity and are assumed critical for lifespan of each 
individual organism. Though the knowledge regarding telomeres and their structural and 
functional regulation in dividing somatic tissues has grown enormously, corresponding issues 
in the post-mitotic brain are still not fully investigated. This is mainly due to the lack of 
adequate protocols for the isolation of neural cells and analysis of telomere length dynamics 
in interphase nuclei. In our study, we developed a protocol for the vital extraction of neural 
cells from the murine brain cortex, and combined this technique with a Flow-FISH-based 
approach in order to assess average telomere lengths in the healthy ageing murine brain (Ain 
et al., in preparation). As a further step, we assessed the effect of hermetic versus 
conventional inbreeding strategies on telomere length and integrity. Moreover, to determine 
the dependence of telomere length dynamics on the cell cycle activity in the post-mitotic 
interphase and moderately replicative neural cell populations in the CNS, we coupled Flow-
FISH to PI-based DNA content analyses and specified RTL as a function of cell cycle 
activity. For some selected conditions, data obtained by Flow-FISH were verified by a PCR-
based telomere length determination performed in isolated cells from corresponding tissue 
samples. Additionally, RTL dynamics were complemented by analyses on telomerase enzyme 
activity and NF-κB RelA expression. Furthermore, disease-associated changes in telomere 
length and telomerase activity were determined for different CNS regions in hSOD1
G93A
 
transgenic mice, a well-established animal model for ALS.  
 Telomere length dynamics and telomerase activity in the ageing brain 5.1
In the first part of the study related to the healthy ageing model, we observed telomere 
shortening independently of any cell cycle activity in cortical neural cells isolated from a 
hermetically inbred mouse sub-strain, but not in the conventionally inbred sister colony. 
Comparing RTL of G0/G1 and G2 phase cell populations from identical samples revealed that 
telomere attrition was more pronounced in the cells with active cell cycle. Telomere erosion 
in the neocortex of this hermetically inbred B6Je colony was accompanied by stabilized levels 
of TERT activity relative to the conventionally inbred B6J colony.   
Since brain cortex is a region which shows a high vulnerability towards ageing-associated 
decay and thus is implicated in several neurodegenerative disorders (Ma et al., 2015; Raskin 
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et al., 2015), we specified the changes in RTL and telomerase activity primarily in the 
neocortex of the healthy young and senescent murine brain. Moreover, adult cortex is a non-
neurogenic region, which is devoid of a self-replicative pool (Agasse et al., 2004). These 
features exclude a possible contribution of neural stem cells to the profound telomere 
shortening effect observed in the B6Je colony particularly for cell populations in the G2 phase 
of the cell cycle. Furthermore, we regularly performed tissue perfusion prior to neural cell 
isolation to rule out any bias from the peripheral blood cell pool interfering with the telomere 
length measurements.   
Isolation of neural cells from adult rodent brain tissue and downstream molecular analysis is 
technically challenging owing to the complex layered structure of several brain regions 
including the cortex (Lee et al., 2011), and is further complicated by the diverse cellular 
interactions between different neuronal and glial populations (Guez-Barber et al., 2012). 
Moreover, though there are many working protocols available for the isolation of neurons 
from different brain regions at embryonic and early postnatal ages (Pacifici and Peruzzi, 
2012; Seibenhener and Wooten, 2012; Feldmann et al., 2014),  only few working algorithms 
describe strategies for cell isolation from the mature CNS (Brewer, 1997; Brewer and 
Torricelli, 2007). Thus, the first step was to overcome these technical limitations and develop 
a protocol for the isolation of neural cells from the young as well as senescent murine CNS. 
The primary downstream application of such cell isolation was to measure RTL using an 
innovative Flow-FISH approach. Guez-Barber and his colleagues described means for neural 
cell isolation from the rat brain using accutase enzyme, followed by FACS purification of 
specific cell types (Guez-Barber et al., 2012). In analogy, we used this enzyme solution, 
composed of a mixture of collagenolytic and proteolytic enzymes, for neural cell isolation. 
However, the procedure failed technically in spite of a series of optimization steps, owing to 
the incomplete digestion of the tissue by this enzymatic compound, even when used at a 
working temperature optimal for such enzymes. Another potential problem could be the 
application to a brain region and species different from the experimental set up used in the 
work published by Guez-Barber and colleagues (Guez-Barber et al., 2012), both factors which 
implicate changes in tissue amount, composition and intercellular adhesion. Thereby, the 
authors (Guez-Barber et al., 2012) isolated cells from cerebral striatum or midbrain in the rat, 
whereas murine cortex was the region of interest in our study. Finally, by replacing accutase 
with papain enzyme and adding D-trehalose along with mechanical dissociation, we 
succeeded to develop a consistent working protocol for neural cell isolation from adult murine 
brain. Moreover, this newly established protocol proved to be a very valuable tool for cell 
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isolation from highly aged mice and for different CNS regions like cortex and spinal cord, 
thereby implicating that the isolated cells are suitable for many downstream applications 
including Flow-FISH, FACS, DNA extraction and qPCR (Ain et al., in preparation) and 
Comet assay (Penndorf et al., 2017). 
To the best of our knowledge, this is the first study commencing telomere length 
determination under true neurosenescent conditions by using highly aged mice, beyond 24 
months of age, and specified for replicative and non-replicative brain-derived neural cells. 
Though Flow-FISH, like TRF analysis and qPCR-based strategies, provides the average 
measurement of RTL, this approach was the only method currently available which enabled 
us to dissect between different cell cycle phases and thus bridged the knowledge between 
non-dividing interphase cells in G0/G1 phase and the cells with replicative potential, namely 
the G2 phase moiety. One additional advantage of Flow-FISH over southern blotting and 
qPCR-based approaches is the putative cell type-specific analysis. However, coupling of 
Flow-FISH with classical immunocytochemistry under our conditions did not reach the 
required validity. We are currently optimizing Flow-FISH protocol coupled with a neuron-
specific staining with Neu-O dye. Though yet not described as part of the thesis, this 
technique will now allow us to specify telomere length alterations directly in purified neurons 
(Ain et al., in preparation). 
RTL determination in isolated cortical neural cells with Flow-FISH was later validated by 
qPCR-based telomere length measurement. Since qPCR-based strategies do not allow for cell 
cycle discrimination, Flow-FISH analysis and gating strategies required adjustment for 
comparison with qPCR-derived results. Thereby, RTL was evaluated selectively in the gate 
“singlets” without further discrimination of the cell cycle phases. Applying such comparison, 
age-associated reduction in RTL of cortical neural cells was confirmed with both 
methodological variants, though the effect was more pronounced when RTL was assayed by 
Flow-FISH as compared to the qPCR-based procedure. The difference observed in the 
severity of telomere length reduction might underlie several methodological and analytical 
reasons. In principal, the congruent pattern obtained by both methods substantiates the 
preciosity of our RTL determinations and might also support the establishment of a 
conclusive picture of telomere length dynamics in the ageing brain. Moreover, qPCR-based 
telomere length measurement in the murine CNS for different conditions like ageing and ALS 
provided an estimate of stable, reduced or even elongated telomeres which implicate the 
reliability and authenticity of the procedure. Further, currently ongoing analyses, 
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implementing Neu-O-based selection of neurons coupled with RTL measurement either by 
qPCR or Flow-FISH will further elucidate contribution of specific cell types to RTL changes 
in the CNS.  
In this study, one of the novel and fundamental findings was that telomere shortening in the 
healthy ageing brain occurs not only in replication-active glial cells with a moderate but life-
long cell cycle activity but also in non-replicative neural cells, seemingly including neurons. 
Though, telomere attrition in these non-dividing cells was less profound than in the cells with 
sustained cell cycle activity. However, this telomere shortening was only observed in the 
hermetically inbred B6Je colony. Moreover, though average telomere length in the replicative 
cortical cell population was not reduced by ageing in isolates derived from a conventionally 
inbred mouse strain, there was at least a strong tendency towards an age-associated shortening 
(p = 0.052). The telomere length in the G0/G1 arrested cell population remained unaffected by 
ageing in this mouse colony. Thus, the present data also substantiate that telomere integrity in 
the brain is affected by genomic factors, as demonstrated by the profound impact of breeding 
conditions on ageing-dependent and ageing-independent telomere length alterations. The 
presence of longer telomeres in the hermetically inbred young B6Je mice along with a higher 
rate of age-associated telomere attrition show that lack of genetic refreshment severely 
impacts on the length and integrity of the telomeres. Our data not only endorse previous 
findings about the lengthening of telomeres under consanguineous breeding conditions as 
described for blood cells (Manning et al., 2002) but also confirm it for brain cell populations. 
The data additionally provide evidence that hermetic inbreeding conditions reinforce telomere 
shortening with ageing in the murine brain, despite of its low replicative cell turnover. These 
observations are consistent with the notion that consanguinity exerts deleterious effects on the 
genome stability and integrity in general (Ruiz-Lopez et al., 2010). Moreover, exclusion of 
genetic refreshment as in the case of our B6Je colony can further lead to the occurrence of a 
genetic drift due to inheritance of deleterious genomic mutations (Casellas, 2011), a 
phenomenon which is associated with accelerated ageing and reduced lifespan in small inbred 
colonies (Lohr et al., 2014).  
Owing to the basically post-mitotic nature of the CNS, there are only few studies addressing 
the subject of telomere length dynamics in the mammalian brain (Coviello-McLaughlin and 
Prowse, 1997; Takubo et al., 2002; Cherif et al., 2003; Flanary and Streit, 2003; Nakamura et 
al., 2007; Takubo et al., 2010; Dlouha et al., 2014). Flanary and Streit reported telomere 
shortening in the cortex and cerebellum of rat brains, with ages ranging between P21 and 5 
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months when analyzed by TRF (Flanary and Streit, 2003). However, brains at higher ages 
were not addressed in this study. In contrast, in a contemporary study, telomere lengths in the 
rat brain were described to remain stable at least up to the age of 15 months when compared 
to P21 and 3 months old controls, though region-specific telomere length dynamics were not 
concealed in this study (Cherif et al., 2003). In a previous study using southern blotting for 
the TRF-based telomere length assessment, no age-associated or region-dependent changes in 
the average telomere length were observed in the cerebellum, hippocampus and sub-
ventricular zone of the murine brain, (Coviello-McLaughlin and Prowse, 1997). Likewise, in 
human postmortem cerebral cortex derived from individuals at ages between 0-104 years, no 
changes in the average length of those telomeres was detected (Takubo et al., 2002; Takubo et 
al., 2010). However, the rate of extremely short telomeres (<6kb) was found to be increased 
to an extent comparable with other replicative tissues (Takubo et al., 2010). In contrast, in the 
rat ageing brain no increase in the moiety of short telomeres was reported (Cherif et al., 
2003).  
The discrepancy in results obtained by different studies can be subjected to the variations 
arising from the different brain regions analyzed and heterogeneous age categories included in 
these studies. This also reflects the need for further approaches to clarify the nature of 
telomere length changes in the CNS. Subsequently, the strategy developed in our study 
represents a feasible approach to address this highly relevant issue. 
The increase in the levels of reactive oxygen species (ROS) and subsequent DNA damage in 
the ageing brain (Ishii et al., 2017) serves as underlying mechanism in the pathology of 
various neurodegenerative diseases (Beal et al., 1997; Zhu et al., 2000). Additionally, 
guanine-rich telomeres are more prone to acquire permanent oxidation-mediated DNA 
damage  and telomere erosion (Kawanishi and Oikawa, 2004; Coluzzi et al., 2014). Thus, 
beside the replication-associated telomere reduction, which is relevant in particular for our 
cells in G2 phase, ROS-mediated telomere damage may contribute to the telomere attrition 
process and provide an explanation for the telomere shortening detected in the non-replicative 
neural cell pool. The coincidence of telomere erosion in both the replicative and non-
replicative cell moieties of the B6Je strain with sustained levels of TERT activity may point 
to the induction of protective roles of the telomerase enzyme, which are known to counteract 
ROS-mediated cellular stress (Ahmed et al., 2008; Haendeler et al., 2009). However, the 
interplay between increased ROS-mediated DNA damage with ageing and TERT activity 
needs to be further elucidated. 
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Furthermore, our data show a shift in neural cell cycle activity with ageing, as marked by an 
increment in the DNA content of cortical neural cells isolated from both murine sister 
colonies. In general, the DNA histograms based on the PI staining established for the aged 
samples from both murine cohorts displayed a consistent pattern and exhibited a shift towards 
a higher frequency of cells with an increased DNA content as compared with the samples 
from young animals. Beside the observation that aged mice displayed an increment in the 
number of cells with higher DNA content, the proportion of the cells in G0/G1 phase 
decreased as compared to the young animals. Thus, our data provide evidence for the re-
induction of the atypical cell cycle activity in the ageing brain as described previously (Zhang 
and Herrup, 2011). However, the identity of the cell types which displayed the DNA content 
variation due to regular or abortive cell cycle activity is yet not defined. Moreover, up to 50% 
of these neural cells in the cortical cell isolates appeared to have neuronal identity, reflecting 
that neurons are also subjected to DNA content variations along with glial cell populations, 
despite the existence of life-long intrinsic control processes to block replication (Herrup and 
Yang, 2007). This observation supports some previous evidences referring that up to 10-20% 
of the cortical neurons, both under healthy brain ageing and under AD pathology display a 
higher DNA content than expected for neurons in a stable, quiescent G0 phase (Mosch et al., 
2007; Fischer et al., 2012). The DNA content variations observed in these neurons might 
point to loss of control on cell cycle activity, which then can trigger aberrant and abortive cell 
cycle re-entry and ultimately leads to neuronal death (Arendt and Brückner, 2007; Zhang and 
Herrup, 2011).  
The analysis of the activity of the TERT subunit of the telomerase enzyme, which is 
responsible for the de novo addition of the telomere repeats to the chromosomal ends, also 
showed strain-specific differences. The relatively maintained levels of TERT at higher age in 
the hermetically inbred sub-strain as compared to the conventionally inbred colony might 
reflect a sort of compensatory mechanism to overcome the faster rate of telomere erosion in 
the extremely inbred strain. Sustained levels of cortical TERT activity in the B6Je colony 
relative to the B6J mice might also be related to extra-telomeric functions of TERT. Likewise, 
TERT is thought to be involved in cell protective, anti-apoptotic, proliferative and survival 
functions. With regard to the canonical functions of the telomerase enzyme, TERT activity 
was long assumed to be restricted to highly proliferative organs such as the intestine, and to 
stem cell niches. However, different studies have pointed to the existence of substantial TERT 
expression and activity in the adult mammalian brain. Flanary and Streit showed a steady 
increment in the TERT activity levels in cortex and cerebellum of adult rats from day 21 up to 
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6 months of age. In their study, however, they did not explore the TERT activity in highly 
aged animals (Flanary and Streit, 2003). In the human brain, on the contrary, TERT activity 
was shown to already decline during fetal development and attain undetectable levels in 
adults. In contrast, TERT protein levels were discovered to increase steadily from 
development to adulthood in the human brain (Ishaq et al., 2016). Differential patterns of 
TERT protein expression and activity levels during development and adulthood suggest that 
these two elements do not correlate with each other. Eitan and colleagues (2016) further 
characterized the relationship between TERT protein and activity levels in different sub-
cellular fractions of the murine cortex at ages ranging from prenatal day 14 to 20-22 months, 
and found a negative correlation between the TERT protein and enzyme activity level in the 
cytoplasmic and nuclear-bound fractions. In particular, the nuclear-bound fraction displayed 
low TERT activity levels at embryonic state but augmented activity levels with ageing, 
whereas the protein levels were decreased at adult stage (Eitan et al., 2016). In contrast, the 
cytoplasmic fraction presented very high TERT activity levels at the embryonic stage, which 
then decreased with ageing, while an opposite regulation was described for the TERT protein 
levels in the same fraction (Eitan et al., 2016). All these studies point to a differential 
regulation of TERT activity and protein and its involvement in non-canonical functions in the 
brain. Likewise, execution of conventional telomere elongation functions requires nuclear 
TERT protein expression and activity, whereas cytoplasmic location might implicate 
alternative TERT actions such as ROS-neutralization in mitochondria. Accordingly, 
constitutive TERT protein expression in different brain regions of rodents is assumed to be 
crucial for the regulation of normal organ function (Lee et al., 2010). Additionally, following 
oxidative stress exposure, 80-90% of TERT protein translocates from the nucleus to 
mitochondria and improves the mitochondrial function by causing an increase in 
mitochondrial membrane potential and by supporting the reduction of ROS production 
(Ahmed et al., 2008). Also, TERT has been shown to protect the mitochondrial DNA itself 
against UV-induced DNA damage (Haendeler et al., 2009). Spilsbury and colleagues showed 
similar nucleus-to-mitochondria translocation of TERT in the human hippocampus isolated 
from AD patients at advanced disease stages and pointed to a protective role against Tau-
related pathology (Spilsbury et al., 2015). Furthermore, in somatic tissues including post-
mitotic brain, TERT can improve tissue regeneration and rejuvenation and enhance cell 
survival, as TERT exerts anti-apoptotic functions in neurons after various kinds of ischemic 
and neurotoxic insults (Zhu et al., 2000; Fu et al., 2002; Kang et al., 2004; Jaskelioff et al., 
2011). However, the requirement of a certain subcellular TERT location to perform such 
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rejuvenation and survival functions is still undefined. At least, these studies suggest the 
prevalence and functional relevance of enzymatically active and inactive TERT protein in the 
non-regenerative regions of the post-mitotic brain, not only at the developmental stages but 
also at higher chronological ages. In line with these findings, we observed substantial TERT 
activity in the non-neurogenic murine cortex isolated from young and aged mice of both B6 
cohorts. Thus, detected shorter telomeres and sustained levels of TERT activity in the 
neocortex of aged B6Je mice as compared to their young counterparts might point to a 
counteracting response to reduce neurosenescence and maintain tissue homeostasis. However, 
a specific protective effect of TERT on the highly vulnerable telomeres in the ageing brain 
needs to be further elucidated. 
TERT also interacts with different transcription factors and modulates several cell signaling 
pathways, for example the Wnt/β catenin pathway (Park et al., 2009; Zhang et al., 2012; 
Listerman et al., 2014) and NF-κB pathway (Yin et al., 2000; Ghosh et al., 2012). NF-κB is a 
cardinal regulator of ageing-associated genetic re-modelling in different tissues including the 
CNS. Constitutive activation of NF-κB and its downstream targets mediate chronic 
inflammation, also in the ageing brain via telomere dysfunction and accelerated senescence 
(Adler et al., 2007; Jurk et al., 2014). NF-κB interacts with TERT promoter regions and 
activates TERT expression (Yin et al., 2000) and, in turn, the NF-κB canonical pathway is 
regulated by a feed-forward interaction between TERT and the RelA subunit of NF-κB 
(Ghosh et al., 2012; Wu et al., 2016). In a malignant environment, NF-κB RelA and TERT 
expression levels are simultaneously augmented (Wang et al., 2004b; Ghosh et al., 2012). 
Moreover, in healthy to malignant cell transformation as assessed by in vitro systems, TERT 
directly stimulates the binding of RelA to the NF-κB downstream target gene promoters by 
inducing the RelA, but not c-Rel subunit of canonical NF-κB. Such interplay then leads to the 
up-regulation of the NF-κB inflammatory pathway. Subsequently, sustained and high levels 
of NF-κB target genes enhance the TERT expression via a feed-forward loop (Ghosh et al., 
2012). A similar molecular interaction between TERT and NF-κB RelA subunit was recently 
proposed for the mouse model of alcoholic liver disease (ALD) (Wu et al., 2016). 
In light of such evidences reported for malignant conditions, our findings regarding relatively 
sustained TERT activity levels in the neocortex of senescent B6Je mice prompted us to 
examine the expression levels of NF-κB RelA in the healthy ageing murine brain. 
Accordingly, RelA expression levels were found significantly higher in the neocortex of the 
aged B6Je colony as compared to their young littermates as well as relative to the aged B6J 
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mice, which showed significant age-associated reduction in the levels of the TERT activity. 
Thus, sustained TERT activity was accompanied by a corresponding up-regulation of RelA 
expression in the aged B6Je sub-strain, which displayed accelerated telomere erosion. These 
data also suggest that a similar feed-forward interaction between TERT and NF-κB RelA 
might exist in the CNS, as recently described in a malignant environment. In analogy, 
augmented RelA expression levels may partially contribute to the relatively unchanged TERT 
activity levels observed in the hermetically inbred aged B6Je colony. On the other hand, the 
observed increase in the RelA expression level in the ageing brain of the B6Je sub-strain also 
supports the prevailing notion of increased inflammation in the ageing brain (Gabuzda and 
Yankner, 2013). Such interplay may also accentuate the complex and indefinite role of NF-κB 
in healthy tissue aging in general, and underline its crucial role in mediating ageing-associated 
inflammation of the brain. We also observed a significant decrease in the expression levels of 
c-Rel in the aged B6J colony as compared to their young counterparts and also in comparison 
to the aged B6Je sub-strain, and this was accompanied by a significant reduction in TERT 
activity levels. Interestingly, knockout of c-Rel has been associated to an ageing phenotype in 
the mouse brain (Lanzillotta et al., 2015). Whether TERT is involved in direct or indirect 
regulation of c-Rel of canonical NF-κB is yet unclear and needs further examination. It will 
also be interesting to see whether TERT supports cell survival and homeostasis in the CNS, 
e.g., via interaction with canonical NF-κB subunits such as RelA and c-Rel. Furthermore, 
influence of breeding conditions and genetic refreshment on such molecular loops is not yet 
explored.  
 Disease-associated changes in telomere length and telomerase activity  5.2
Although the telomere length of the chromosomes in the healthy ageing human brain is 
currently thought to remain unaltered (Takubo et al., 2002; Takubo et al., 2010), loss of 
telomere integrity, either detected in blood or directly in CNS tissue, has indeed been 
associated with many neurodegenerative disorders (Panossian et al., 2003; Thomas et al., 
2008; Kota et al., 2014). Nevertheless, such studies are still few, and only a rare number is 
addressing the role of telomere integrity and telomerase activity in the ALS disorder (Eitan et 
al., 2012; De Felice et al., 2014; Eitan et al., 2016; Linkus et al., 2016). ALS is an age-
associated disease of the central and peripheral nervous system, which implicates progressive 
demise of motor neurons and associated neuro-muscular units. Its pathology is characterized 
by a rapidly progressing paralysis of bulbar, skeletal and respiratory muscles, which 
ultimately leads to the death of the individuals (reviewed by D’Amico et al., 2013; Paulukonis 
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et al., 2015).The underlying mechanisms involved in ALS-related pathological 
neurodegeneration are complex and not yet apprehended completely. A frequently used 
animal model resembling human ALS pathology is the hSOD1
G93A
 transgenic mouse model 
which expresses a high copy number of a mutated human super oxide dismutase 1 (hSOD1) 
gene.  
In the second part of the study, we analyzed the disease-associated changes in telomere length 
dynamics in CNS regions principally affected by the disease course, including the neocortex 
and cervical spinal cord derived from hSOD1
G93A
 transgenic mice. Surprisingly, we observed 
a remarkable lengthening of telomeres at the advanced stage of the disease in both cortex and 
cervical spinal cord as compared with age-matched control and pre-symptomatic mice. These 
results are unexpected in light of the association of intact telomeres with genomic and 
functional cell preservation. Moreover, in a recent study Linkus and colleagues showed stable 
and unaltered telomere lengths in neurons and astrocytes from hippocampus of human ALS 
patients (Linkus et al., 2016). Interestingly, in the same study, Linkus and colleagues found a 
tendency towards longer telomeres in microglia as compared to the healthy controls (Linkus 
et al., 2016). Likewise, previous studies conducted with material derived from human patients 
suffering from neurodegenerative AD either showed unaltered telomere length (Lukens et al., 
2009) or shortened telomeres as compared to healthy controls (Franco et al., 2006). However, 
in support of our findings, a recent study by Thomas and co-workers also discovered longer 
telomeres in hippocampi from AD patients as compared to the healthy controls, and this was 
seemingly observed without any gender effect (Thomas et al., 2008). Since hippocampus is 
known to possess regenerative capacity from its stem cell pool throughout the adult lifespan, 
which normally leads to telomere attrition in respective dividing populations, such findings of 
unaltered or elongated telomeres are similarly unexplained. They are also  in opposition to a 
previous study showing telomere erosion in hippocampal neurons from AD patients (Franco 
et al., 2006). The possible mechanism responsible for the telomere lengthening observed in 
hippocampus is unknown, but it was proposed to result either from alternative lengthening of 
telomeres (ALT) or be due to a presumed lower frequency in regenerative cell cycle turnover 
in AD affected hippocampi (Thomas et al., 2008). Thus, discrepancies in telomere length 
assessments under neurodegenerative conditions are seemingly not restricted to ALS, but an 
issue unresolved also for AD and maybe other disease entities. Since in our study, both cortex 
and spinal cord tissue from the diseased hSOD1
G93A
 transgenic mice are devoid of 
proliferative activity, low regenerative capacity appears unlikely as a reason for the observed 
telomere lengthening. In contrast, the significant telomere lengthening, which occurred within 
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a short time of 4-5 weeks along with progression of the disease from the pre-symptomatic to 
the symptomatic stage, may be the result of ALT mechanisms. ALT, defined as molecular 
strategies to extend telomeres independently of telomerase activity, can arise from end-to-end 
fusion of very short telomeres, which may occur as a consequence, e.g., of the ALS disease 
process alongside with the loss of TERT activity. ALT is supposed to be active also in the 
absence of extremely short telomeres, can originate from extrachromosomal telomere circles 
or telomere copying events that form along with homologous recombination (HR) in a context 
of telomere instability and is most frequently found in immortalized or tumor cells (Cesare 
and Reddel, 2010, 2013; Samassekou et al., 2013). Moreover, irrespective of HR, 
extrachromosomal telomeric circles can be generated as a result of DNA damage or TERT 
overexpression (Wang et al., 2004a; Fasching et al., 2007; Pickett et al., 2009). The molecular 
bases for the possible role of ALT in the senescent and neurodegenerative CNS still has to be 
explored. Therefore, further analyses, e.g., based on 2D gel electrophoresis will reveal the 
presence of extrachromosomal telomeric circles and high telomere length heterogeneity, 
which serve as hallmarks of ALT (Nabetani and Ishikawa, 2011; Samassekou et al., 2013). 
ALS is characterized by the severe loss of motor neurons especially in spinal cord tissue 
(Kiernan et al., 2011; Brettschneider et al., 2013). Hence, another possible explanation is that 
the increase in telomere length observed for cortex and spinal cord tissue at advanced disease 
stages results from the loss of neural cells with shorter telomeres, with preservation of cell 
populations with still intact telomere ends, thus leading to an apparent telomere elongation.  
Since many motor neurons are lost at advanced disease stage (Kiernan et al., 2011; 
Brettschneider et al., 2013) and microglia displayed a tendency towards longer telomeres in 
human ALS patients, we hypothesized that microglia could be the cell population responsible 
for the lengthening of telomeres detected at late disease stages in hSOD1
G93A
 mice. Moreover, 
microglia are assumed to play a dual role in ALS, with both neuroprotective and neurotoxic 
functions (Liao et al., 2012; Chiu et al., 2013). Therefore, we measured the telomere length in 
isolated cortical microglia from symptomatic and control mice. However, we did not observe 
any changes in microglial telomere length relative to the age-matched controls, which ruled 
out microglia as a potential contributing cell type to the observed lengthening of telomeres. 
Whether other neural cell types are likely to be involved in this increment in the average 
telomere length is still an open question and needs further investigation. Apart from average 
telomere length estimations, analyses on absolute telomere lengths are required to explore 
whether the recognition of longer telomeres under neurodegenerative conditions such as ALS 
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or AD have to be seen in the light of a relative pseudo-elongation, e.g. due to the loss of cells 
with short telomeres, or due to true TTAGGG sequence amplification. 
In spite of the increasing knowledge on the role of TERT protein in the brain, a region-
dependent profile of TERT activity in ALS-susceptible brain and spinal cord regions, and a 
corresponding mapping of enzyme activity versus protein expression levels, alongside with 
the disease process was not explored yet. Therefore in our study, we also assessed the changes 
in TERT activity as a function of the ALS disease progression in the hSOD1
G93A
 mutant 
strain, thereby addressing different CNS regions including the spinal cord. Using a qPCR-
based TRAP assay, TERT activity was found reduced in all the brain regions investigated as 
compared to the asymptomatic mutant mice. In contrast, the cervical spinal cord tissue 
displayed a relative increment in the TERT activity along with disease progression. In a recent 
study, De Felice and colleagues described lower levels of TERT activity in terms of TERT 
protein expression in leucocytes and postmortem spinal cord tissue of ALS patients, relative 
to the controls. Moreover, lower TERT protein expression was also associated with shorter 
telomere lengths in blood leucocytes from these patients relative to the healthy controls (De 
Felice et al., 2014).  It needs further determination whether a low TERT protein expression 
observed in ALS patients directly correlates with a low activity since a direct correlation 
between the TERT protein expression and TERT activity could not be established, at least  for 
the murine organism (Eitan et al., 2016). Thus, our approach to define telomere length and 
TERT activity in a region-specific and disease state-dependent manner aimed to improve our 
current understanding of the telomere biology and specify it for the peculiar conditions of 
neurosenescence and neurodegeneration. 
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6 CONCLUSIONS AND OUTLOOK  
In summary, this study addressed changes in the average telomere length occurring in the 
healthy ageing brain and under ALS-like neurodegenerative conditions. For the first time we 
analyzed telomere length dynamics selectively in replicative and non-replicative cell 
populations of the ageing murine brain and their dependency on genetic refreshment by using 
a Flow-FISH-based approach. Our data reveal that proliferation is not the only prerequisite for 
telomere shortening in the ageing brain. By applying hermetic inbreeding conditions we 
observed replication-independent telomere shortening in post-mitotic neural cells, a 
population which is assumed to contain up to 50% non-dividing neurons. Nonetheless, 
telomere shortening was found more pronounced in the dividing cell moiety. In addition to 
these observations, our data also showed an age-associated induction of cell cycle activity in 
the murine brain, a process recently found to contribute also to neuronal dysfunction and 
death. Further studies are now envisaged to identify the neural cell types responsible for the 
shift in the cell cycle activity and the observed telomere length shortening in the senescent 
brain. Our results also substantiate the influence of other factors like regular genetic 
refreshment on telomere length and rate of telomere erosion in the ageing brain. In this 
context, we show that neural telomere attrition is faster in animals which are devoid of genetic 
refreshment for longer periods. This observation suggests that the rate of telomere shortening 
and not the absolute telomere lengths might serve as a predictive factor for the ageing process 
of an organism. Moreover, under consanguineous breeding conditions, shorter telomere 
lengths both of the dividing and non-dividing neural cells were accompanied by stabilized 
activity levels of TERT subunit of the telomerase enzyme. The enzymatically active moiety of 
telomerase enzyme, which is responsible for preserving telomere length shares a mechanistic 
feed-forward loop with RelA subunit of canonical NF-κB, and this interaction might be 
involved in a putative TERT-RelA-mediated compensatory mechanism to compensate the 
faster rate of telomere shortening observed in the hermetic bred strain. Consistent with this 
hypothesis, unchanged TERT activity levels were accompanied by an increase in the 
expression levels of the NF-κB RelA subunit. Considering additional pleiotropic functions 
exerted by NF-κB in the CNS, molecular or pharmacological interference with TERT-RelA 
interplay may provide a possible target to prevent senescence and modulate degeneration in 
the CNS. However, the observed increase in RelA transcription levels may also due to the 
increased inflammation associated with ageing and thus it would underscore the ambivalent 
roles of NF-κB in the ageing brain. Therefore, one challenging aspect for future studies will 
be to investigate the intricate link between NF-κB pathway and chromosomal integrity and its 
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possible contribution to the underlying mechanism involved in neurosenescence and 
neurodegeneration. 
As a second important aspect, this study provides a disease-associated profile of telomere 
length and telomerase activity in hSOD1
G93A
 mutant mice, an established model for ALS 
pathology. The molecular basis for the telomere lengthening observed in the cortex and spinal 
cord with severity of the disease is currently unknown. However, increased telomere lengths 
in CNS regions vulnerable to ALS-related pathobiology might also be indicative of an 
alternative telomere lengthening process. Such a process of conserved, but unconventional 
telomere elongation implicates an extensive erosion of telomeres as a first step, and a 
subsequent fusion of the arising critically short telomeres, which may be propagated with 
disease progression. It can also be a result of a TERT-independent telomere amplification 
from extrachromosomal telomere circles, though such a mechanism is not yet established 
independently of HR and thus requires consolidation for CNS circumstances. As an 
alternative explanation, the observed lengthening of telomeres might represent a pseudo-
lengthening due to the loss of vulnerable cell populations with relatively short telomeres at 
advanced disease stages. Furthermore, our data also prove a region-specific regulation of 
TERT activity in the diseased CNS, which varies with disease progression. These 
observations provide a basis for future studies, aimed to elucidate the role of telomere biology 
in the pathophysiology of neurosenescence and neurodegeneration, like the ALS-related 
pathology. 
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